Chemical,anthracyclines
Chemical,lapatinib
Disease,acromegaly
Disease,AION
Disease,breastCancer
Disease,breastCancerDetection
Disease,breastCancerDiagnosis
Disease,breastCancers
Disease,breastTumor
Disease,cancer
Disease,cancerCell-relatedComponents
Disease,CBC
Disease,chestWallDisease
Disease,chestWallLesions
Disease,colorectalCancer
Disease,lungCancer
Disease,PA
Disease,pituitaryAdenomas
Disease,prolactinoma
Disease,prolactinomas
Disease,seromaProduction
Disease,TNBC
Disease,triple-negativeBreastCancers
Disease,tumour
Gene,BRCA1
Gene,BRD4
Gene,CXCR4
Other,0.004
Other,1
Other,1062Patients
Other,12-15Percecnt
Other,121Percecnt
Other,121PercecntOfPatients
Other,121PercecntOfPatientsWithProlactinomas
Other,12SampledWomen
Other,18f-fdgPet
Other,18f-fdgPet/ctImages
Other,19
Other,20PercecntIncreasedRisk
Other,20PercecntIncreasedRiskAmongContraceptionUsers
Other,20PercecntIncreasedRiskAmongCurrentContraceptionUsers
Other,20PercecntIncreasedRiskAmongCurrentHormonalContraceptionUsers
Other,20PercecntIncreasedRiskAmongHormonalContraceptionUsers
Other,20PercecntIncreasedRiskOfBreastCancer
Other,20PercecntIncreasedRiskOfBreastCancerAmongContraceptionUsers
Other,20PercecntIncreasedRiskOfBreastCancerAmongCurrentContraceptionUsers
Other,20PercecntIncreasedRiskOfBreastCancerAmongCurrentHormonalContraceptionUsers
Other,20PercecntIncreasedRiskOfBreastCancerAmongHormonalContraceptionUsers
Other,20PercecntRisk
Other,20PercecntRiskAmongContraceptionUsers
Other,20PercecntRiskAmongCurrentContraceptionUsers
Other,20PercecntRiskAmongCurrentHormonalContraceptionUsers
Other,20PercecntRiskAmongHormonalContraceptionUsers
Other,20PercecntRiskOfBreastCancer
Other,20PercecntRiskOfBreastCancerAmongContraceptionUsers
Other,20PercecntRiskOfBreastCancerAmongCurrentContraceptionUsers
Other,20PercecntRiskOfBreastCancerAmongCurrentHormonalContraceptionUsers
Other,20PercecntRiskOfBreastCancerAmongHormonalContraceptionUsers
Other,23Cross-sectionalStudies
Other,23Studies
Other,24ApplicableCases
Other,24Cases
Other,25HPost-injection
Other,25Months
Other,25MonthsFromDiagnosis
Other,3.5
Other,375Percecnt
Other,387Percecnt
Other,40
Other,466Percecnt
Other,52
Other,54Percecnt
Other,56Percecnt
Other,581Patients
Other,60Years
Other,68Ga-Pentixafor
Other,7/18Patients
Other,8/18Cases
Other,825Ml
Other,95PercecntConfidenceIntervals
Other,abbreviatedMriProtocols
Other,accomplished
Other,accumulatedDoseOfTreatment
Other,accumulation
Other,accumulationAnd
Other,accumulationAndInVivo
Other,accumulationInVitroAnd
Other,accumulationInVitroAndInVivo
Other,accumulationOfFluorescentOsteopontin
Other,accumulationOfFluorescentOsteopontinAnd
Other,accumulationOfFluorescentOsteopontinAndInVivo
Other,accumulationOfFluorescentOsteopontinInVitroAnd
Other,accumulationOfFluorescentOsteopontinInVitroAndInVivo
Other,accumulationOfOsteopontin
Other,accumulationOfOsteopontinAnd
Other,accumulationOfOsteopontinAndInVivo
Other,accumulationOfOsteopontinInVitroAnd
Other,accumulationOfOsteopontinInVitroAndInVivo
Other,accurateTissueSampling
Other,additional
Other,additionalAnti-her2Therapy
Other,additionalIndicator
Other,additionalTherapy
Other,address
Other,adjustment
Other,administration
Other,administrationOfOsteopontin-750Probe
Other,adoption
Other,adoptionOfCtn
Other,advancedDiagnosticImaging
Other,advancedImaging
Other,age
Other,agents
Other,agentsUsed
Other,agentsUsedInBreastCancerTreatment
Other,ageOf25Years
Other,ageThanPatients
Other,ageThanPatientsWithFamilyHistory
Other,ageThanPatientsWithNegativeFamilyHistory
Other,aggressiveCourse
Other,aggressiveCourseOfHer2Cancer
Other,agreement
Other,aim
Other,Aims
Other,allFiveCases
Other,allotting
Other,alsoShaped
Other,alternativeContrast-enhancedScreeningTools
Other,alternativeScreeningTools
Other,amongThemIdentifiedInStudy
Other,amongThemNewlyIdentifiedInStudy
Other,amount
Other,amountOfObservedVariation
Other,amountOfObservedVariationInSeromaProduction
Other,amountOfVariation
Other,amountOfVariationInSeromaProduction
Other,analysis
Other,analyzed
Other,Anthracyclines
Other,anti-her2Therapies
Other,anti-her2Therapy
Other,anti-her2Treatment
Other,apoptosis
Other,applied
Other,approach
Other,appropriateness
Other,areAlsoInvestigated
Other,areAlsoInvestigatedForBreastCancerDiagnosis
Other,areInvestigated
Other,areInvestigatedForBreastCancerDiagnosis
Other,areUsed
Other,article
Other,aspirinUse
Other,asResultAreUsed
Other,assessment
Other,association
Other,associationAmongWomen
Other,associationAmongWomenWithBreastCancer
Other,associationBetweenAspirinUse
Other,associationBetweenIntake
Other,associationBetweenIntakeOfB-carotene
Other,associationBetweenLow-doseAspirinUse
Other,associationBetweenPost-diagnosisAspirinUse
Other,associationBetweenPost-diagnosisLow-doseAspirinUse
Other,associationBetweenPost-diagnosisUse
Other,associationBetweenPost-diagnosisUseOfAspirin
Other,associationBetweenPost-diagnosisUseOfLow-doseAspirin
Other,associationBetweenPrediagnosisDietaryIntake
Other,associationBetweenPrediagnosisDietaryIntakeAmongWomen
Other,associationBetweenPrediagnosisDietaryIntakeAmongWomenWithBreastCancer
Other,associationBetweenPrediagnosisDietaryIntakeOfB-carotene
Other,associationBetweenPrediagnosisDietaryIntakeOfB-caroteneAmongWomen
Other,associationBetweenPrediagnosisDietaryIntakeOfB-caroteneAmongWomenWithBreastCancer
Other,associationBetweenPrediagnosisIntake
Other,associationBetweenPrediagnosisIntakeAmongWomen
Other,associationBetweenPrediagnosisIntakeAmongWomenWithBreastCancer
Other,associationBetweenPrediagnosisIntakeOfB-carotene
Other,associationBetweenPrediagnosisIntakeOfB-caroteneAmongWomen
Other,associationBetweenPrediagnosisIntakeOfB-caroteneAmongWomenWithBreastCancer
Other,associationBetweenUse
Other,associationBetweenUseOfAspirin
Other,associationBetweenUseOfLow-doseAspirin
Other,asymptomaticNeuromas
Other,at25HPost-injectionGreaterInTumorBed
Other,at25HPost-injectionGreaterInTumorBedRespectively
Other,at25HPost-injectionGreaterInTumorBedThanInKidney
Other,at25HPost-injectionGreaterInTumorBedThanInKidneyRespectively
Other,at25HPost-injectionGreaterThanInKidney
Other,at25HPost-injectionGreaterThanInKidneyRespectively
Other,available
Other,availableContrastAgents
Other,axillaryLymphNodeMetastasisOfUnknownPrimary
Other,BACKGROUND
Other,barcodeMode
Other,bcMortalityRates
Other,benefits
Other,benign
Other,betInhibitors
Other,betInhibitorsAlreadyAvailable
Other,betInhibitorsAlreadyAvailableInClinic
Other,betInhibitorsAvailable
Other,betInhibitorsAvailableInClinic
Other,betProteins
Other,betterOutcome
Other,betterOutcomeWithGoodNegativePredictiveValue
Other,betterOutcomeWithGoodNegativeValue
Other,betterOutcomeWithGoodPredictiveValue
Other,betterOutcomeWithGoodValue
Other,betterOutcomeWithNegativePredictiveValue
Other,betterOutcomeWithNegativeValue
Other,betterOutcomeWithPredictiveValue
Other,betterOutcomeWithValue
Other,betterUnderstanding
Other,binding
Other,bindingInVitro
Other,bindingToBreastCancerCells
Other,bindingToBreastCancerCellsInVitro
Other,biomarker
Other,biomarkerInPatients
Other,biomarkerInPatientsWithBreastCancer
Other,bleeding
Other,brca1Levels
Other,brca1Wild-typeTnbcCells
Other,brca1Wild-typeTripleNegativeBreastCancer
Other,brcanessPhenotype
Other,brcanessPhenotypeInBrca1TnbcCells
Other,brcanessPhenotypeInBrca1Wild-typeTnbcCells
Other,brd4Inhibition
Other,brd4PharmacologicalInhibition
Other,brd4Regulation
Other,brd4RegulationInDnaRepair
Other,brd4RegulationInHomologousDnaRepair
Other,brd4RegulationInHomologousRecombination-mediatedDnaRepair
Other,brd4RegulationInRecombination-mediatedDnaRepair
Other,Breast
Other,breastCancerEffects
Other,breastCancerPatientsSerum
Other,breastCancerPrognosis
Other,breastExamination
Other,breastImagingModality
Other,breastNeuromas
Other,breastPain
Other,breastTumorInMice
Other,breastTumorInNudeMice
Other,Bromodomain
Other,cancerClustering
Other,cancerClusteringInPatients
Other,cancerClusteringInPatientsWithProlactinoma
Other,cancerComponents
Other,cancerDevelopment
Other,cancerInFemalePatients
Other,cancerInFemalePatientsWorldwide
Other,cancerInPatients
Other,cancerInPatientsWorldwide
Other,cancerRiskPerception
Other,cardiacTroponins
Other,cardiotoxicityDiagnosis
Other,case
Other,caseOfBreastNeuroma
Other,caseOfTraumaticBreastNeuroma
Other,cases
Other,casesWithAsymptomaticNeuromas
Other,casesWithNeuromas
Other,cellCycleRegulators
Other,CIs
Other,clinical
Other,clinicalBiomarker
Other,clinicalBiomarkerInPatients
Other,clinicalBiomarkerInPatientsWithBreastCancer
Other,clinicalBreastExamination
Other,clinicalEntity
Other,clinicalEntityWithCases
Other,clinicalEntityWithCasesHavingReported
Other,clinicalEntityWithCasesHavingReportedToDate
Other,clinicalEntityWithFewCases
Other,clinicalEntityWithFewCasesHavingReported
Other,clinicalEntityWithFewCasesHavingReportedToDate
Other,clinicalEntityWithOnlyCases
Other,clinicalEntityWithOnlyCasesHavingReported
Other,clinicalEntityWithOnlyCasesHavingReportedToDate
Other,clinicalEntityWithOnlyFewCases
Other,clinicalEntityWithOnlyFewCasesHavingReported
Other,clinicalEntityWithOnlyFewCasesHavingReportedToDate
Other,clinicalStrategies
Other,clinicalStudies
Other,clinicians
Other,co-encapsulation
Other,co-encapsulationOfFluorophore
Other,co-encapsulationOfNear-infraredFluorophore
Other,cohort
Other,cohortOfPatients
Other,cohortOfPatientsInOutpatientClinic
Other,cohortOfPatientsWithAdenomas
Other,cohortOfPatientsWithAdenomasInOutpatientClinic
Other,cohortOfPatientsWithPituitaryAdenomas
Other,cohortOfPatientsWithPituitaryAdenomasInOutpatientClinic
Other,cohortStudy
Other,collectedSignatures
Other,combination
Other,combinations
Other,combinationsOfInduction
Other,combinationsOfInductionInBrca1BreastCancer
Other,combinationsOfInductionInBrca1NegativeBreastCancer
Other,combinationsOfInductionInBrca1TripleBreastCancer
Other,combinationsOfInductionInBrca1TripleNegativeBreastCancer
Other,combinationsOfInductionInBrca1Wild-typeBreastCancer
Other,combinationsOfInductionInBrca1Wild-typeNegativeBreastCancer
Other,combinationsOfInductionInBrca1Wild-typeTripleBreastCancer
Other,combinationsOfInductionInBrca1Wild-typeTripleNegativeBreastCancer
Other,commonAgents
Other,commonAgentsUsed
Other,commonAgentsUsedInBreastCancerTreatment
Other,commonCancer
Other,commonlyDiagnosed
Other,compared
Other,comparedSemi-quantitatively
Other,Comparison
Other,complex
Other,complexDisease
Other,components
Other,comprehensiveSearch
Other,concerns
Other,conclusion
Other,confidenceIntervals
Other,confirmation
Other,confirmationOfSignalAccumulation
Other,confirmationOfSignalAccumulationUsing
Other,confirmationOfSignalAccumulationUsingNearFluorescentImaging
Other,confirmationOfSignalAccumulationUsingNearImaging
Other,confirmationOfSignalAccumulationUsingNearInfraredFluorescentImaging
Other,confirmationOfSignalAccumulationUsingNearInfraredImaging
Other,confirmationUsing
Other,confirmationUsingNearFluorescentImaging
Other,confirmationUsingNearImaging
Other,confirmationUsingNearInfraredFluorescentImaging
Other,confirmationUsingNearInfraredImaging
Other,confirmed
Other,conservativeTreatment
Other,consistent
Other,consultation
Other,continuing
Other,contraceptionUse
Other,contrastAfterInjection
Other,contrastAgent
Other,contrastAgents
Other,contrast-enhancedScreeningTools
Other,contrastWithImagingModalities
Other,conventionalImaging
Other,conventionalX-rayMammography
Other,copyright
Other,cornerstone
Other,correspondingCohort
Other,costOfMriExamination
Other,costs
Other,course
Other,courseOfHer2Cancer
Other,coxHazardRegressionModels
Other,coxProportionalHazardRegressionModels
Other,cTn
Other,ctnLevels
Other,currentDevelopments
Other,currentlyImplemented
Other,currentlyImplementedInScreeningAtIncreasedRisk
Other,currentlyImplementedInScreeningAtIncreasedRiskOfBreastCancer
Other,currentlyImplementedInScreeningAtRisk
Other,currentlyImplementedInScreeningAtRiskOfBreastCancer
Other,currentlyImplementedInScreeningOfWomenAtIncreasedRisk
Other,currentlyImplementedInScreeningOfWomenAtIncreasedRiskOfBreastCancer
Other,currentlyImplementedInScreeningOfWomenAtRisk
Other,currentlyImplementedInScreeningOfWomenAtRiskOfBreastCancer
Other,currentlyOnlyRoutinelyImplemented
Other,currentlyOnlyRoutinelyImplementedInScreeningAtIncreasedRisk
Other,currentlyOnlyRoutinelyImplementedInScreeningAtIncreasedRiskOfBreastCancer
Other,currentlyOnlyRoutinelyImplementedInScreeningAtRisk
Other,currentlyOnlyRoutinelyImplementedInScreeningAtRiskOfBreastCancer
Other,currentlyOnlyRoutinelyImplementedInScreeningOfWomenAtIncreasedRisk
Other,currentlyOnlyRoutinelyImplementedInScreeningOfWomenAtIncreasedRiskOfBreastCancer
Other,currentlyOnlyRoutinelyImplementedInScreeningOfWomenAtRisk
Other,currentlyOnlyRoutinelyImplementedInScreeningOfWomenAtRiskOfBreastCancer
Other,currentlyRoutinelyImplemented
Other,currentlyRoutinelyImplementedInScreeningAtIncreasedRisk
Other,currentlyRoutinelyImplementedInScreeningAtIncreasedRiskOfBreastCancer
Other,currentlyRoutinelyImplementedInScreeningAtRisk
Other,currentlyRoutinelyImplementedInScreeningAtRiskOfBreastCancer
Other,currentlyRoutinelyImplementedInScreeningOfWomenAtIncreasedRisk
Other,currentlyRoutinelyImplementedInScreeningOfWomenAtIncreasedRiskOfBreastCancer
Other,currentlyRoutinelyImplementedInScreeningOfWomenAtRisk
Other,currentlyRoutinelyImplementedInScreeningOfWomenAtRiskOfBreastCancer
Other,currentUsersOfLongerDuration
Other,cxcr4-directedPetImaging
Other,cxcr4ExpressionDeterminedByImmunohistochemistry
Other,cxcr4-targetedPetImaging
Other,cxcr4-targetedPetProbe68ga-pentixafor
Other,danishCohortStudy
Other,decades
Other,decreases
Other,decreasesInBcMortalityRates
Other,definitiveDiagnosis
Other,denseBreasts
Other,designed
Other,detectable
Other,detection
Other,detectionInWomen
Other,detectionOfBreastCancer
Other,detectionOfBreastCancerInWomen
Other,deterioration
Other,developed
Other,developedCbcAmong
Other,developedCbcDuring
Other,development
Other,diagnosed
Other,diagnosedWithPaAtAge
Other,diagnosedWithPaAtAgeThanPatients
Other,diagnosedWithPaAtAgeThanPatientsWithFamilyHistory
Other,diagnosedWithPaAtAgeThanPatientsWithNegativeFamilyHistory
Other,diagnosedWithPaAtEarlierAge
Other,diagnosedWithPaAtEarlierAgeThanPatients
Other,diagnosedWithPaAtEarlierAgeThanPatientsWithFamilyHistory
Other,diagnosedWithPaAtEarlierAgeThanPatientsWithNegativeFamilyHistory
Other,diagnosis
Other,diagnosisInPatients
Other,diagnosisInPatientsWithHistory
Other,diagnosisInPatientsWithHistoryOfBreastSurgery
Other,diagnosisOfAcuteCoronarySyndromes
Other,diagnosisOfAcuteSyndromes
Other,diagnosisOfBreastCancer
Other,diagnosisOfCardiotoxicity
Other,diagnosisOfCoronarySyndromes
Other,diagnosisOfResponse
Other,diagnosisOfResponseToTreatment
Other,diagnosisOfSyndromes
Other,diagnosisProcess
Other,diagnosticEvaluation
Other,diagnosticImaging
Other,diagnosticPerformance
Other,diagnosticPerformanceInPatients
Other,diagnosticPerformanceInPatientsWithBreastCancer
Other,diagnosticPerformanceOfCxcr4-directedPetImaging
Other,diagnosticPerformanceOfCxcr4-directedPetImagingInPatients
Other,diagnosticPerformanceOfCxcr4-directedPetImagingInPatientsWithBreastCancer
Other,diagnosticPerformanceOfPetImaging
Other,diagnosticPerformanceOfPetImagingInPatients
Other,diagnosticPerformanceOfPetImagingInPatientsWithBreastCancer
Other,diagnosticSensitivity
Other,diagnosticSensitivityForWomen
Other,diagnosticSensitivityForWomenWithBreasts
Other,diagnosticSensitivityForWomenWithDenseBreasts
Other,diet
Other,differentBiomarkers
Other,differentContrastAgent
Other,differentialDiagnosis
Other,differentialDiagnosisInPatients
Other,differentialDiagnosisInPatientsWithHistory
Other,differentialDiagnosisInPatientsWithHistoryOfBreastSurgery
Other,differentiallyExpressed
Other,differentiallyExpressedInFourTypes
Other,differentiallyExpressedInFourTypesOfBreastCancer
Other,differentStudies
Other,directional
Other,directRelationship
Other,discovery
Other,discussed
Other,disease
Other,dnaDamage
Other,dnaDamageRegulation
Other,dose-dependentReduction
Other,dose-dependentReductionInBrca1Levels
Other,doses
Other,dualApproach
Other,due
Other,earlierAge
Other,earlierAgeThanPatients
Other,earlierAgeThanPatientsWithFamilyHistory
Other,earlierAgeThanPatientsWithNegativeFamilyHistory
Other,earlyDiagnosis
Other,earlyDiagnosisOfCardiotoxicity
Other,effectiveDiagnosis
Other,effectiveDiagnosisOfBreastCancer
Other,effectiveTechniqueused
Other,effectsModel
Other,Efforts
Other,elderlyPatient
Other,elderlyPatientWithHer2
Other,elderlyPatientWithRelapsedHer2
Other,enhancement
Other,enhancementOfImage
Other,entity
Other,entityWithCases
Other,entityWithCasesHavingReported
Other,entityWithCasesHavingReportedToDate
Other,entityWithFewCases
Other,entityWithFewCasesHavingReported
Other,entityWithFewCasesHavingReportedToDate
Other,entityWithOnlyCases
Other,entityWithOnlyCasesHavingReported
Other,entityWithOnlyCasesHavingReportedToDate
Other,entityWithOnlyFewCases
Other,entityWithOnlyFewCasesHavingReported
Other,entityWithOnlyFewCasesHavingReportedToDate
Other,errors
Other,established
Other,estimated
Other,evaluated
Other,evaluatedInVivo
Other,evaluation
Other,evidence
Other,evidenced
Other,evidencedByIncrease
Other,evidencedByIncreaseInContrast
Other,evidencedByIncreaseInContrastAfterInjection
Other,evidenceForAssociation
Other,evidenceForAssociationAmongWomen
Other,evidenceForAssociationAmongWomenWithBreastCancer
Other,evidenceForAssociationBetweenPrediagnosisDietaryIntake
Other,evidenceForAssociationBetweenPrediagnosisDietaryIntakeAmongWomen
Other,evidenceForAssociationBetweenPrediagnosisDietaryIntakeAmongWomenWithBreastCancer
Other,evidenceForAssociationBetweenPrediagnosisDietaryIntakeOfB-carotene
Other,evidenceForAssociationBetweenPrediagnosisDietaryIntakeOfB-caroteneAmongWomen
Other,evidenceForAssociationBetweenPrediagnosisDietaryIntakeOfB-caroteneAmongWomenWithBreastCancer
Other,evidenceForAssociationBetweenPrediagnosisIntake
Other,evidenceForAssociationBetweenPrediagnosisIntakeAmongWomen
Other,evidenceForAssociationBetweenPrediagnosisIntakeAmongWomenWithBreastCancer
Other,evidenceForAssociationBetweenPrediagnosisIntakeOfB-carotene
Other,evidenceForAssociationBetweenPrediagnosisIntakeOfB-caroteneAmongWomen
Other,evidenceForAssociationBetweenPrediagnosisIntakeOfB-caroteneAmongWomenWithBreastCancer
Other,evidenceForInverseAssociation
Other,evidenceForInverseAssociationAmongWomen
Other,evidenceForInverseAssociationAmongWomenWithBreastCancer
Other,evidenceForInverseAssociationBetweenPrediagnosisDietaryIntake
Other,evidenceForInverseAssociationBetweenPrediagnosisDietaryIntakeAmongWomen
Other,evidenceForInverseAssociationBetweenPrediagnosisDietaryIntakeAmongWomenWithBreastCancer
Other,evidenceForInverseAssociationBetweenPrediagnosisDietaryIntakeOfB-carotene
Other,evidenceForInverseAssociationBetweenPrediagnosisDietaryIntakeOfB-caroteneAmongWomen
Other,evidenceForInverseAssociationBetweenPrediagnosisDietaryIntakeOfB-caroteneAmongWomenWithBreastCancer
Other,evidenceForInverseAssociationBetweenPrediagnosisIntake
Other,evidenceForInverseAssociationBetweenPrediagnosisIntakeAmongWomen
Other,evidenceForInverseAssociationBetweenPrediagnosisIntakeAmongWomenWithBreastCancer
Other,evidenceForInverseAssociationBetweenPrediagnosisIntakeOfB-carotene
Other,evidenceForInverseAssociationBetweenPrediagnosisIntakeOfB-caroteneAmongWomen
Other,evidenceForInverseAssociationBetweenPrediagnosisIntakeOfB-caroteneAmongWomenWithBreastCancer
Other,evidenceForSignificantlyInverseAssociation
Other,evidenceForSignificantlyInverseAssociationAmongWomen
Other,evidenceForSignificantlyInverseAssociationAmongWomenWithBreastCancer
Other,evidenceForSignificantlyInverseAssociationBetweenPrediagnosisDietaryIntake
Other,evidenceForSignificantlyInverseAssociationBetweenPrediagnosisDietaryIntakeAmongWomen
Other,evidenceForSignificantlyInverseAssociationBetweenPrediagnosisDietaryIntakeAmongWomenWithBreastCancer
Other,evidenceForSignificantlyInverseAssociationBetweenPrediagnosisDietaryIntakeOfB-carotene
Other,evidenceForSignificantlyInverseAssociationBetweenPrediagnosisDietaryIntakeOfB-caroteneAmongWomen
Other,evidenceForSignificantlyInverseAssociationBetweenPrediagnosisDietaryIntakeOfB-caroteneAmongWomenWithBreastCancer
Other,evidenceForSignificantlyInverseAssociationBetweenPrediagnosisIntake
Other,evidenceForSignificantlyInverseAssociationBetweenPrediagnosisIntakeAmongWomen
Other,evidenceForSignificantlyInverseAssociationBetweenPrediagnosisIntakeAmongWomenWithBreastCancer
Other,evidenceForSignificantlyInverseAssociationBetweenPrediagnosisIntakeOfB-carotene
Other,evidenceForSignificantlyInverseAssociationBetweenPrediagnosisIntakeOfB-caroteneAmongWomen
Other,evidenceForSignificantlyInverseAssociationBetweenPrediagnosisIntakeOfB-caroteneAmongWomenWithBreastCancer
Other,excision
Other,exhibiting
Other,existingContrastAgents
Other,experiences
Other,exposureLag
Other,expressed
Other,expressedInFourTypes
Other,expressedInFourTypesOfBreastCancer
Other,extra-terminalBetProteins
Other,factor
Other,familialCancerClustering
Other,familialCancerClusteringInPatients
Other,familialCancerClusteringInPatientsWithProlactinoma
Other,familyHistory
Other,familyHistoryOfCancer
Other,familyImpact
Other,familyMember
Other,familyMemberAffected
Other,familyMemberAffectedWithCancer
Other,familyMembers
Other,farHasAssociated
Other,farHasAssociatedWithMutations
Other,farHasAssociatedWithMutationsInBrca1
Other,farHasMainlyAssociated
Other,farHasMainlyAssociatedWithMutations
Other,farHasMainlyAssociatedWithMutationsInBrca1
Other,feasible
Other,feasibleInCasesAfterAccurateTissueSampling
Other,feasibleInCasesAfterTissueSampling
Other,feasibleInCasesWithAsymptomaticNeuromasAfterAccurateTissueSampling
Other,feasibleInCasesWithAsymptomaticNeuromasAfterTissueSampling
Other,feasibleInCasesWithNeuromasAfterAccurateTissueSampling
Other,feasibleInCasesWithNeuromasAfterTissueSampling
Other,feasibleInProperlySelectedCasesAfterAccurateTissueSampling
Other,feasibleInProperlySelectedCasesAfterTissueSampling
Other,feasibleInProperlySelectedCasesWithAsymptomaticNeuromasAfterAccurateTissueSampling
Other,feasibleInProperlySelectedCasesWithAsymptomaticNeuromasAfterTissueSampling
Other,feasibleInProperlySelectedCasesWithNeuromasAfterAccurateTissueSampling
Other,feasibleInProperlySelectedCasesWithNeuromasAfterTissueSampling
Other,feasibleInSelectedCasesAfterAccurateTissueSampling
Other,feasibleInSelectedCasesAfterTissueSampling
Other,feasibleInSelectedCasesWithAsymptomaticNeuromasAfterAccurateTissueSampling
Other,feasibleInSelectedCasesWithAsymptomaticNeuromasAfterTissueSampling
Other,feasibleInSelectedCasesWithNeuromasAfterAccurateTissueSampling
Other,feasibleInSelectedCasesWithNeuromasAfterTissueSampling
Other,features
Other,femalePatients
Other,femalePatientsWorldwide
Other,femaleSibling
Other,fewCases
Other,filipinoWomen
Other,finances
Other,finding
Other,firstDiagnosisOfBreastCancer
Other,five
Other,fiveDoses
Other,fiveDosesOfAdjuvantTranstuzumab
Other,fiveDosesOfTranstuzumab
Other,flowCytometry
Other,fluorescenceImagingExVivo
Other,fluorescent
Other,fluorescentDye
Other,fluorescentImaging
Other,fluorescentImagingInNegative
Other,fluorescentImagingInNegativeInVitro
Other,fluorescentImagingInTripleNegative
Other,fluorescentImagingInTripleNegativeInVitro
Other,follow-up
Other,follow-upOf48Years
Other,formed
Other,formedByCo-encapsulationInMicelles
Other,formedByCo-encapsulationInPegylatedMicelles
Other,formedByCo-encapsulationOfFluorophoreInMicelles
Other,formedByCo-encapsulationOfFluorophoreInPegylatedMicelles
Other,formedByCo-encapsulationOfNear-infraredFluorophoreInMicelles
Other,formedByCo-encapsulationOfNear-infraredFluorophoreInPegylatedMicelles
Other,formulation
Other,formulationOfEffectiveManagementPlan
Other,formulationOfEffectiveManagementPlanForAt-riskWomen
Other,formulationOfEffectiveManagementPlanForWomen
Other,formulationOfManagementPlan
Other,formulationOfManagementPlanForAt-riskWomen
Other,formulationOfManagementPlanForWomen
Other,forty-threeCases
Other,found
Other,fourPatients
Other,fourTypes
Other,fourTypesOfBreastCancer
Other,furtherDevelopment
Other,furthermoreDiagnosed
Other,furthermoreDiagnosedWithPaAtAge
Other,furthermoreDiagnosedWithPaAtAgeThanPatients
Other,furthermoreDiagnosedWithPaAtAgeThanPatientsWithFamilyHistory
Other,furthermoreDiagnosedWithPaAtAgeThanPatientsWithNegativeFamilyHistory
Other,furthermoreDiagnosedWithPaAtEarlierAge
Other,furthermoreDiagnosedWithPaAtEarlierAgeThanPatients
Other,furthermoreDiagnosedWithPaAtEarlierAgeThanPatientsWithFamilyHistory
Other,furthermoreDiagnosedWithPaAtEarlierAgeThanPatientsWithNegativeFamilyHistory
Other,furtherResearch
Other,geneExpression
Other,gene-expression-basedPrognosticSignatures
Other,gene-expression-basedSignatures
Other,generallyReserved
Other,givenConcernsAboutContrastAgentsAreAlsoInvestigated
Other,givenConcernsAboutContrastAgentsAreAlsoInvestigatedForBreastCancerDiagnosis
Other,givenConcernsAboutContrastAgentsAreInvestigated
Other,givenConcernsAboutContrastAgentsAreInvestigatedForBreastCancerDiagnosis
Other,givenConcernsAboutGadolinium-basedContrastAgentsAreAlsoInvestigated
Other,givenConcernsAboutGadolinium-basedContrastAgentsAreAlsoInvestigatedForBreastCancerDiagnosis
Other,givenConcernsAboutGadolinium-basedContrastAgentsAreInvestigated
Other,givenConcernsAboutGadolinium-basedContrastAgentsAreInvestigatedForBreastCancerDiagnosis
Other,givenConcernsAreAlsoInvestigated
Other,givenConcernsAreAlsoInvestigatedForBreastCancerDiagnosis
Other,givenConcernsAreInvestigated
Other,givenConcernsAreInvestigatedForBreastCancerDiagnosis
Other,givenRecentConcernsAboutContrastAgentsAreAlsoInvestigated
Other,givenRecentConcernsAboutContrastAgentsAreAlsoInvestigatedForBreastCancerDiagnosis
Other,givenRecentConcernsAboutContrastAgentsAreInvestigated
Other,givenRecentConcernsAboutContrastAgentsAreInvestigatedForBreastCancerDiagnosis
Other,givenRecentConcernsAboutGadolinium-basedContrastAgentsAreAlsoInvestigated
Other,givenRecentConcernsAboutGadolinium-basedContrastAgentsAreAlsoInvestigatedForBreastCancerDiagnosis
Other,givenRecentConcernsAboutGadolinium-basedContrastAgentsAreInvestigated
Other,givenRecentConcernsAboutGadolinium-basedContrastAgentsAreInvestigatedForBreastCancerDiagnosis
Other,givenRecentConcernsAreAlsoInvestigated
Other,givenRecentConcernsAreAlsoInvestigatedForBreastCancerDiagnosis
Other,givenRecentConcernsAreInvestigated
Other,givenRecentConcernsAreInvestigatedForBreastCancerDiagnosis
Other,glycosylation
Other,glycosylationOfMembraneTypeMr
Other,glycosylationSites
Other,goodNegativePredictiveValue
Other,greater
Other,greaterInTumorBedThanInKidney
Other,greaterInTumorBedThanInKidneyRespectively
Other,greaterRespectively
Other,harmfulorHarmlessTissues
Other,harmfulorTissues
Other,hasApplied
Other,hasAppliedToEarlyIdentification
Other,hasAppliedToIdentification
Other,hasAssociated
Other,hasAssociatedWithMutations
Other,hasAssociatedWithMutationsInBrca1
Other,hasFound
Other,hasInconsistent
Other,hasMainlyAssociated
Other,hasMainlyAssociatedWithMutations
Other,hasMainlyAssociatedWithMutationsInBrca1
Other,haveDeveloped
Other,haveIntroduced
Other,haveReported
Other,haveReportedAfterMastectomy
Other,haveReportedMainlyAfterMastectomy
Other,haveValidated
Other,haveValidatedByClinicalStudies
Other,haveValidatedByClinicalStudiesInCardiotoxicityDiagnosis
Other,haveValidatedByClinicalStudiesInCardiotoxicityDiagnosisInPatients
Other,haveValidatedByClinicalStudiesInCardiotoxicityDiagnosisInPatientsMainlyWithTrastuzumab
Other,haveValidatedByClinicalStudiesInCardiotoxicityDiagnosisInPatientsTreated
Other,haveValidatedByClinicalStudiesInCardiotoxicityDiagnosisInPatientsTreatedMainlyWithTrastuzumab
Other,haveValidatedByClinicalStudiesInCardiotoxicityDiagnosisInPatientsTreatedWithDoses
Other,haveValidatedByClinicalStudiesInCardiotoxicityDiagnosisInPatientsTreatedWithDosesInCombination
Other,haveValidatedByClinicalStudiesInCardiotoxicityDiagnosisInPatientsTreatedWithDosesInCombinationMainlyWithTrastuzumab
Other,haveValidatedByClinicalStudiesInCardiotoxicityDiagnosisInPatientsTreatedWithDosesInCombinationWithTrastuzumab
Other,haveValidatedByClinicalStudiesInCardiotoxicityDiagnosisInPatientsTreatedWithDosesMainlyWithTrastuzumab
Other,haveValidatedByClinicalStudiesInCardiotoxicityDiagnosisInPatientsTreatedWithDosesOfAnthracyclines
Other,haveValidatedByClinicalStudiesInCardiotoxicityDiagnosisInPatientsTreatedWithDosesOfAnthracyclinesAlone
Other,haveValidatedByClinicalStudiesInCardiotoxicityDiagnosisInPatientsTreatedWithDosesOfAnthracyclinesAloneInCombination
Other,haveValidatedByClinicalStudiesInCardiotoxicityDiagnosisInPatientsTreatedWithDosesOfAnthracyclinesAloneInCombinationMainlyWithTrastuzumab
Other,haveValidatedByClinicalStudiesInCardiotoxicityDiagnosisInPatientsTreatedWithDosesOfAnthracyclinesAloneInCombinationWithTrastuzumab
Other,haveValidatedByClinicalStudiesInCardiotoxicityDiagnosisInPatientsTreatedWithDosesOfAnthracyclinesAloneMainlyWithTrastuzumab
Other,haveValidatedByClinicalStudiesInCardiotoxicityDiagnosisInPatientsTreatedWithDosesOfAnthracyclinesAloneWithTrastuzumab
Other,haveValidatedByClinicalStudiesInCardiotoxicityDiagnosisInPatientsTreatedWithDosesOfAnthracyclinesInCombination
Other,haveValidatedByClinicalStudiesInCardiotoxicityDiagnosisInPatientsTreatedWithDosesOfAnthracyclinesInCombinationMainlyWithTrastuzumab
Other,haveValidatedByClinicalStudiesInCardiotoxicityDiagnosisInPatientsTreatedWithDosesOfAnthracyclinesInCombinationWithTrastuzumab
Other,haveValidatedByClinicalStudiesInCardiotoxicityDiagnosisInPatientsTreatedWithDosesOfAnthracyclinesMainlyWithTrastuzumab
Other,haveValidatedByClinicalStudiesInCardiotoxicityDiagnosisInPatientsTreatedWithDosesOfAnthracyclinesWithTrastuzumab
Other,haveValidatedByClinicalStudiesInCardiotoxicityDiagnosisInPatientsTreatedWithDosesWithTrastuzumab
Other,haveValidatedByClinicalStudiesInCardiotoxicityDiagnosisInPatientsTreatedWithHighDoses
Other,haveValidatedByClinicalStudiesInCardiotoxicityDiagnosisInPatientsTreatedWithHighDosesInCombination
Other,haveValidatedByClinicalStudiesInCardiotoxicityDiagnosisInPatientsTreatedWithHighDosesInCombinationMainlyWithTrastuzumab
Other,haveValidatedByClinicalStudiesInCardiotoxicityDiagnosisInPatientsTreatedWithHighDosesInCombinationWithTrastuzumab
Other,haveValidatedByClinicalStudiesInCardiotoxicityDiagnosisInPatientsTreatedWithHighDosesMainlyWithTrastuzumab
Other,haveValidatedByClinicalStudiesInCardiotoxicityDiagnosisInPatientsTreatedWithHighDosesOfAnthracyclines
Other,haveValidatedByClinicalStudiesInCardiotoxicityDiagnosisInPatientsTreatedWithHighDosesOfAnthracyclinesAlone
Other,haveValidatedByClinicalStudiesInCardiotoxicityDiagnosisInPatientsTreatedWithHighDosesOfAnthracyclinesAloneInCombination
Other,haveValidatedByClinicalStudiesInCardiotoxicityDiagnosisInPatientsTreatedWithHighDosesOfAnthracyclinesAloneInCombinationMainlyWithTrastuzumab
Other,haveValidatedByClinicalStudiesInCardiotoxicityDiagnosisInPatientsTreatedWithHighDosesOfAnthracyclinesAloneInCombinationWithTrastuzumab
Other,haveValidatedByClinicalStudiesInCardiotoxicityDiagnosisInPatientsTreatedWithHighDosesOfAnthracyclinesAloneMainlyWithTrastuzumab
Other,haveValidatedByClinicalStudiesInCardiotoxicityDiagnosisInPatientsTreatedWithHighDosesOfAnthracyclinesAloneWithTrastuzumab
Other,haveValidatedByClinicalStudiesInCardiotoxicityDiagnosisInPatientsTreatedWithHighDosesOfAnthracyclinesInCombination
Other,haveValidatedByClinicalStudiesInCardiotoxicityDiagnosisInPatientsTreatedWithHighDosesOfAnthracyclinesInCombinationMainlyWithTrastuzumab
Other,haveValidatedByClinicalStudiesInCardiotoxicityDiagnosisInPatientsTreatedWithHighDosesOfAnthracyclinesInCombinationWithTrastuzumab
Other,haveValidatedByClinicalStudiesInCardiotoxicityDiagnosisInPatientsTreatedWithHighDosesOfAnthracyclinesMainlyWithTrastuzumab
Other,haveValidatedByClinicalStudiesInCardiotoxicityDiagnosisInPatientsTreatedWithHighDosesOfAnthracyclinesWithTrastuzumab
Other,haveValidatedByClinicalStudiesInCardiotoxicityDiagnosisInPatientsTreatedWithHighDosesWithTrastuzumab
Other,haveValidatedByClinicalStudiesInCardiotoxicityDiagnosisInPatientsTreatedWithTrastuzumab
Other,haveValidatedByClinicalStudiesInCardiotoxicityDiagnosisInPatientsWithTrastuzumab
Other,haveValidatedByClinicalStudiesInCardiotoxicityDiagnosisMainlyWithTrastuzumab
Other,haveValidatedByClinicalStudiesInCardiotoxicityDiagnosisWithTrastuzumab
Other,haveValidatedByClinicalStudiesMainlyWithTrastuzumab
Other,haveValidatedByClinicalStudiesWithTrastuzumab
Other,haveValidatedByStudies
Other,haveValidatedByStudiesInCardiotoxicityDiagnosis
Other,haveValidatedByStudiesInCardiotoxicityDiagnosisInPatients
Other,haveValidatedByStudiesInCardiotoxicityDiagnosisInPatientsMainlyWithTrastuzumab
Other,haveValidatedByStudiesInCardiotoxicityDiagnosisInPatientsTreated
Other,haveValidatedByStudiesInCardiotoxicityDiagnosisInPatientsTreatedMainlyWithTrastuzumab
Other,haveValidatedByStudiesInCardiotoxicityDiagnosisInPatientsTreatedWithDoses
Other,haveValidatedByStudiesInCardiotoxicityDiagnosisInPatientsTreatedWithDosesInCombination
Other,haveValidatedByStudiesInCardiotoxicityDiagnosisInPatientsTreatedWithDosesInCombinationMainlyWithTrastuzumab
Other,haveValidatedByStudiesInCardiotoxicityDiagnosisInPatientsTreatedWithDosesInCombinationWithTrastuzumab
Other,haveValidatedByStudiesInCardiotoxicityDiagnosisInPatientsTreatedWithDosesMainlyWithTrastuzumab
Other,haveValidatedByStudiesInCardiotoxicityDiagnosisInPatientsTreatedWithDosesOfAnthracyclines
Other,haveValidatedByStudiesInCardiotoxicityDiagnosisInPatientsTreatedWithDosesOfAnthracyclinesAlone
Other,haveValidatedByStudiesInCardiotoxicityDiagnosisInPatientsTreatedWithDosesOfAnthracyclinesAloneInCombination
Other,haveValidatedByStudiesInCardiotoxicityDiagnosisInPatientsTreatedWithDosesOfAnthracyclinesAloneInCombinationMainlyWithTrastuzumab
Other,haveValidatedByStudiesInCardiotoxicityDiagnosisInPatientsTreatedWithDosesOfAnthracyclinesAloneInCombinationWithTrastuzumab
Other,haveValidatedByStudiesInCardiotoxicityDiagnosisInPatientsTreatedWithDosesOfAnthracyclinesAloneMainlyWithTrastuzumab
Other,haveValidatedByStudiesInCardiotoxicityDiagnosisInPatientsTreatedWithDosesOfAnthracyclinesAloneWithTrastuzumab
Other,haveValidatedByStudiesInCardiotoxicityDiagnosisInPatientsTreatedWithDosesOfAnthracyclinesInCombination
Other,haveValidatedByStudiesInCardiotoxicityDiagnosisInPatientsTreatedWithDosesOfAnthracyclinesInCombinationMainlyWithTrastuzumab
Other,haveValidatedByStudiesInCardiotoxicityDiagnosisInPatientsTreatedWithDosesOfAnthracyclinesInCombinationWithTrastuzumab
Other,haveValidatedByStudiesInCardiotoxicityDiagnosisInPatientsTreatedWithDosesOfAnthracyclinesMainlyWithTrastuzumab
Other,haveValidatedByStudiesInCardiotoxicityDiagnosisInPatientsTreatedWithDosesOfAnthracyclinesWithTrastuzumab
Other,haveValidatedByStudiesInCardiotoxicityDiagnosisInPatientsTreatedWithDosesWithTrastuzumab
Other,haveValidatedByStudiesInCardiotoxicityDiagnosisInPatientsTreatedWithHighDoses
Other,haveValidatedByStudiesInCardiotoxicityDiagnosisInPatientsTreatedWithHighDosesInCombination
Other,haveValidatedByStudiesInCardiotoxicityDiagnosisInPatientsTreatedWithHighDosesInCombinationMainlyWithTrastuzumab
Other,haveValidatedByStudiesInCardiotoxicityDiagnosisInPatientsTreatedWithHighDosesInCombinationWithTrastuzumab
Other,haveValidatedByStudiesInCardiotoxicityDiagnosisInPatientsTreatedWithHighDosesMainlyWithTrastuzumab
Other,haveValidatedByStudiesInCardiotoxicityDiagnosisInPatientsTreatedWithHighDosesOfAnthracyclines
Other,haveValidatedByStudiesInCardiotoxicityDiagnosisInPatientsTreatedWithHighDosesOfAnthracyclinesAlone
Other,haveValidatedByStudiesInCardiotoxicityDiagnosisInPatientsTreatedWithHighDosesOfAnthracyclinesAloneInCombination
Other,haveValidatedByStudiesInCardiotoxicityDiagnosisInPatientsTreatedWithHighDosesOfAnthracyclinesAloneInCombinationMainlyWithTrastuzumab
Other,haveValidatedByStudiesInCardiotoxicityDiagnosisInPatientsTreatedWithHighDosesOfAnthracyclinesAloneInCombinationWithTrastuzumab
Other,haveValidatedByStudiesInCardiotoxicityDiagnosisInPatientsTreatedWithHighDosesOfAnthracyclinesAloneMainlyWithTrastuzumab
Other,haveValidatedByStudiesInCardiotoxicityDiagnosisInPatientsTreatedWithHighDosesOfAnthracyclinesAloneWithTrastuzumab
Other,haveValidatedByStudiesInCardiotoxicityDiagnosisInPatientsTreatedWithHighDosesOfAnthracyclinesInCombination
Other,haveValidatedByStudiesInCardiotoxicityDiagnosisInPatientsTreatedWithHighDosesOfAnthracyclinesInCombinationMainlyWithTrastuzumab
Other,haveValidatedByStudiesInCardiotoxicityDiagnosisInPatientsTreatedWithHighDosesOfAnthracyclinesInCombinationWithTrastuzumab
Other,haveValidatedByStudiesInCardiotoxicityDiagnosisInPatientsTreatedWithHighDosesOfAnthracyclinesMainlyWithTrastuzumab
Other,haveValidatedByStudiesInCardiotoxicityDiagnosisInPatientsTreatedWithHighDosesOfAnthracyclinesWithTrastuzumab
Other,haveValidatedByStudiesInCardiotoxicityDiagnosisInPatientsTreatedWithHighDosesWithTrastuzumab
Other,haveValidatedByStudiesInCardiotoxicityDiagnosisInPatientsTreatedWithTrastuzumab
Other,haveValidatedByStudiesInCardiotoxicityDiagnosisInPatientsWithTrastuzumab
Other,haveValidatedByStudiesInCardiotoxicityDiagnosisMainlyWithTrastuzumab
Other,haveValidatedByStudiesInCardiotoxicityDiagnosisWithTrastuzumab
Other,haveValidatedByStudiesMainlyWithTrastuzumab
Other,haveValidatedByStudiesWithTrastuzumab
Other,haveValidatedMainlyWithTrastuzumab
Other,haveValidatedWithTrastuzumab
Other,hazardRatios
Other,healthcarePolicyMakers
Other,henceCurrentlyImplemented
Other,henceCurrentlyImplementedInScreeningAtIncreasedRisk
Other,henceCurrentlyImplementedInScreeningAtIncreasedRiskOfBreastCancer
Other,henceCurrentlyImplementedInScreeningAtRisk
Other,henceCurrentlyImplementedInScreeningAtRiskOfBreastCancer
Other,henceCurrentlyImplementedInScreeningOfWomenAtIncreasedRisk
Other,henceCurrentlyImplementedInScreeningOfWomenAtIncreasedRiskOfBreastCancer
Other,henceCurrentlyImplementedInScreeningOfWomenAtRisk
Other,henceCurrentlyImplementedInScreeningOfWomenAtRiskOfBreastCancer
Other,henceCurrentlyOnlyRoutinelyImplemented
Other,henceCurrentlyOnlyRoutinelyImplementedInScreeningAtIncreasedRisk
Other,henceCurrentlyOnlyRoutinelyImplementedInScreeningAtIncreasedRiskOfBreastCancer
Other,henceCurrentlyOnlyRoutinelyImplementedInScreeningAtRisk
Other,henceCurrentlyOnlyRoutinelyImplementedInScreeningAtRiskOfBreastCancer
Other,henceCurrentlyOnlyRoutinelyImplementedInScreeningOfWomenAtIncreasedRisk
Other,henceCurrentlyOnlyRoutinelyImplementedInScreeningOfWomenAtIncreasedRiskOfBreastCancer
Other,henceCurrentlyOnlyRoutinelyImplementedInScreeningOfWomenAtRisk
Other,henceCurrentlyOnlyRoutinelyImplementedInScreeningOfWomenAtRiskOfBreastCancer
Other,henceCurrentlyRoutinelyImplemented
Other,henceCurrentlyRoutinelyImplementedInScreeningAtIncreasedRisk
Other,henceCurrentlyRoutinelyImplementedInScreeningAtIncreasedRiskOfBreastCancer
Other,henceCurrentlyRoutinelyImplementedInScreeningAtRisk
Other,henceCurrentlyRoutinelyImplementedInScreeningAtRiskOfBreastCancer
Other,henceCurrentlyRoutinelyImplementedInScreeningOfWomenAtIncreasedRisk
Other,henceCurrentlyRoutinelyImplementedInScreeningOfWomenAtIncreasedRiskOfBreastCancer
Other,henceCurrentlyRoutinelyImplementedInScreeningOfWomenAtRisk
Other,henceCurrentlyRoutinelyImplementedInScreeningOfWomenAtRiskOfBreastCancer
Other,henceImplemented
Other,henceImplementedInScreeningAtIncreasedRisk
Other,henceImplementedInScreeningAtIncreasedRiskOfBreastCancer
Other,henceImplementedInScreeningAtRisk
Other,henceImplementedInScreeningAtRiskOfBreastCancer
Other,henceImplementedInScreeningOfWomenAtIncreasedRisk
Other,henceImplementedInScreeningOfWomenAtIncreasedRiskOfBreastCancer
Other,henceImplementedInScreeningOfWomenAtRisk
Other,henceImplementedInScreeningOfWomenAtRiskOfBreastCancer
Other,henceOnlyRoutinelyImplemented
Other,henceOnlyRoutinelyImplementedInScreeningAtIncreasedRisk
Other,henceOnlyRoutinelyImplementedInScreeningAtIncreasedRiskOfBreastCancer
Other,henceOnlyRoutinelyImplementedInScreeningAtRisk
Other,henceOnlyRoutinelyImplementedInScreeningAtRiskOfBreastCancer
Other,henceOnlyRoutinelyImplementedInScreeningOfWomenAtIncreasedRisk
Other,henceOnlyRoutinelyImplementedInScreeningOfWomenAtIncreasedRiskOfBreastCancer
Other,henceOnlyRoutinelyImplementedInScreeningOfWomenAtRisk
Other,henceOnlyRoutinelyImplementedInScreeningOfWomenAtRiskOfBreastCancer
Other,henceRoutinelyImplemented
Other,henceRoutinelyImplementedInScreeningAtIncreasedRisk
Other,henceRoutinelyImplementedInScreeningAtIncreasedRiskOfBreastCancer
Other,henceRoutinelyImplementedInScreeningAtRisk
Other,henceRoutinelyImplementedInScreeningAtRiskOfBreastCancer
Other,henceRoutinelyImplementedInScreeningOfWomenAtIncreasedRisk
Other,henceRoutinelyImplementedInScreeningOfWomenAtIncreasedRiskOfBreastCancer
Other,henceRoutinelyImplementedInScreeningOfWomenAtRisk
Other,henceRoutinelyImplementedInScreeningOfWomenAtRiskOfBreastCancer
Other,herDisease
Other,herEjectionFraction
Other,herPresentation
Other,heterogeneousCancer
Other,heterogeneousCancerInFemalePatients
Other,heterogeneousCancerInFemalePatientsWorldwide
Other,heterogeneousCancerInPatients
Other,heterogeneousCancerInPatientsWorldwide
Other,highCosts
Other,higher
Other,higherResolution
Other,higherRisk
Other,higherRiskForMalignancy
Other,higherSuvmax
Other,higherThanInFamilies
Other,higherThanInFamiliesOfNfpaPatients
Other,highIndex
Other,highlyExpressed
Other,high-resolutionImages
Other,highSensitivity
Other,historicallyInvolved
Other,historyOfBreast-conservingSurgery
Other,historyOfBreastSurgery
Other,historyOfTranstuzumab-inducedCardiacDysfunction
Other,homologousRecombination-mediatedDnaRepair
Other,homologousRecombinationPathway
Other,hormonalContraceptionUse
Other,howeverLower
Other,howeverNon-ideal
Other,howeverSignificantlyLower
Other,howeverUnderutilized
Other,HRs
Other,humanErrors
Other,I2
Other,identification
Other,identified
Other,images
Other,imagesneed
Other,imaging
Other,imagingFeatures
Other,imagingInNegative
Other,imagingInNegativeInVitro
Other,imagingInTripleNegative
Other,imagingInTripleNegativeInVitro
Other,imagingInvestigations
Other,imagingModalities
Other,imagingProtocol
Other,imagingTechnique
Other,implemented
Other,implementedInScreeningAtIncreasedRisk
Other,implementedInScreeningAtIncreasedRiskOfBreastCancer
Other,implementedInScreeningAtRisk
Other,implementedInScreeningAtRiskOfBreastCancer
Other,implementedInScreeningOfWomenAtIncreasedRisk
Other,implementedInScreeningOfWomenAtIncreasedRiskOfBreastCancer
Other,implementedInScreeningOfWomenAtRisk
Other,implementedInScreeningOfWomenAtRiskOfBreastCancer
Other,importantCornerstone
Other,improvedBreastCancerOs
Other,improvedDetection
Other,inception
Other,included
Other,inclusionCriteria
Other,inConclusionNecessaryAsBiomarker
Other,inConclusionNecessaryAsBiomarkerInPatients
Other,inConclusionNecessaryAsBiomarkerInPatientsWithBreastCancer
Other,inConclusionNecessaryAsClinicalBiomarker
Other,inConclusionNecessaryAsClinicalBiomarkerInPatients
Other,inConclusionNecessaryAsClinicalBiomarkerInPatientsWithBreastCancer
Other,inConclusionNecessaryAsRoutineBiomarker
Other,inConclusionNecessaryAsRoutineBiomarkerInPatients
Other,inConclusionNecessaryAsRoutineBiomarkerInPatientsWithBreastCancer
Other,inConclusionNecessaryAsRoutineClinicalBiomarker
Other,inConclusionNecessaryAsRoutineClinicalBiomarkerInPatients
Other,inConclusionNecessaryAsRoutineClinicalBiomarkerInPatientsWithBreastCancer
Other,inConclusionNecessaryForAdoption
Other,inConclusionNecessaryForAdoptionAsBiomarker
Other,inConclusionNecessaryForAdoptionAsBiomarkerInPatients
Other,inConclusionNecessaryForAdoptionAsBiomarkerInPatientsWithBreastCancer
Other,inConclusionNecessaryForAdoptionAsClinicalBiomarker
Other,inConclusionNecessaryForAdoptionAsClinicalBiomarkerInPatients
Other,inConclusionNecessaryForAdoptionAsClinicalBiomarkerInPatientsWithBreastCancer
Other,inConclusionNecessaryForAdoptionAsRoutineBiomarker
Other,inConclusionNecessaryForAdoptionAsRoutineBiomarkerInPatients
Other,inConclusionNecessaryForAdoptionAsRoutineBiomarkerInPatientsWithBreastCancer
Other,inConclusionNecessaryForAdoptionAsRoutineClinicalBiomarker
Other,inConclusionNecessaryForAdoptionAsRoutineClinicalBiomarkerInPatients
Other,inConclusionNecessaryForAdoptionAsRoutineClinicalBiomarkerInPatientsWithBreastCancer
Other,inConclusionNecessaryForAdoptionOfCtn
Other,inConclusionNecessaryForAdoptionOfCtnAsBiomarker
Other,inConclusionNecessaryForAdoptionOfCtnAsBiomarkerInPatients
Other,inConclusionNecessaryForAdoptionOfCtnAsBiomarkerInPatientsWithBreastCancer
Other,inConclusionNecessaryForAdoptionOfCtnAsClinicalBiomarker
Other,inConclusionNecessaryForAdoptionOfCtnAsClinicalBiomarkerInPatients
Other,inConclusionNecessaryForAdoptionOfCtnAsClinicalBiomarkerInPatientsWithBreastCancer
Other,inConclusionNecessaryForAdoptionOfCtnAsRoutineBiomarker
Other,inConclusionNecessaryForAdoptionOfCtnAsRoutineBiomarkerInPatients
Other,inConclusionNecessaryForAdoptionOfCtnAsRoutineBiomarkerInPatientsWithBreastCancer
Other,inConclusionNecessaryForAdoptionOfCtnAsRoutineClinicalBiomarker
Other,inConclusionNecessaryForAdoptionOfCtnAsRoutineClinicalBiomarkerInPatients
Other,inConclusionNecessaryForAdoptionOfCtnAsRoutineClinicalBiomarkerInPatientsWithBreastCancer
Other,inConclusionStillNecessaryAsBiomarker
Other,inConclusionStillNecessaryAsBiomarkerInPatients
Other,inConclusionStillNecessaryAsBiomarkerInPatientsWithBreastCancer
Other,inConclusionStillNecessaryAsClinicalBiomarker
Other,inConclusionStillNecessaryAsClinicalBiomarkerInPatients
Other,inConclusionStillNecessaryAsClinicalBiomarkerInPatientsWithBreastCancer
Other,inConclusionStillNecessaryAsRoutineBiomarker
Other,inConclusionStillNecessaryAsRoutineBiomarkerInPatients
Other,inConclusionStillNecessaryAsRoutineBiomarkerInPatientsWithBreastCancer
Other,inConclusionStillNecessaryAsRoutineClinicalBiomarker
Other,inConclusionStillNecessaryAsRoutineClinicalBiomarkerInPatients
Other,inConclusionStillNecessaryAsRoutineClinicalBiomarkerInPatientsWithBreastCancer
Other,inConclusionStillNecessaryForAdoption
Other,inConclusionStillNecessaryForAdoptionAsBiomarker
Other,inConclusionStillNecessaryForAdoptionAsBiomarkerInPatients
Other,inConclusionStillNecessaryForAdoptionAsBiomarkerInPatientsWithBreastCancer
Other,inConclusionStillNecessaryForAdoptionAsClinicalBiomarker
Other,inConclusionStillNecessaryForAdoptionAsClinicalBiomarkerInPatients
Other,inConclusionStillNecessaryForAdoptionAsClinicalBiomarkerInPatientsWithBreastCancer
Other,inConclusionStillNecessaryForAdoptionAsRoutineBiomarker
Other,inConclusionStillNecessaryForAdoptionAsRoutineBiomarkerInPatients
Other,inConclusionStillNecessaryForAdoptionAsRoutineBiomarkerInPatientsWithBreastCancer
Other,inConclusionStillNecessaryForAdoptionAsRoutineClinicalBiomarker
Other,inConclusionStillNecessaryForAdoptionAsRoutineClinicalBiomarkerInPatients
Other,inConclusionStillNecessaryForAdoptionAsRoutineClinicalBiomarkerInPatientsWithBreastCancer
Other,inConclusionStillNecessaryForAdoptionOfCtn
Other,inConclusionStillNecessaryForAdoptionOfCtnAsBiomarker
Other,inConclusionStillNecessaryForAdoptionOfCtnAsBiomarkerInPatients
Other,inConclusionStillNecessaryForAdoptionOfCtnAsBiomarkerInPatientsWithBreastCancer
Other,inConclusionStillNecessaryForAdoptionOfCtnAsClinicalBiomarker
Other,inConclusionStillNecessaryForAdoptionOfCtnAsClinicalBiomarkerInPatients
Other,inConclusionStillNecessaryForAdoptionOfCtnAsClinicalBiomarkerInPatientsWithBreastCancer
Other,inConclusionStillNecessaryForAdoptionOfCtnAsRoutineBiomarker
Other,inConclusionStillNecessaryForAdoptionOfCtnAsRoutineBiomarkerInPatients
Other,inConclusionStillNecessaryForAdoptionOfCtnAsRoutineBiomarkerInPatientsWithBreastCancer
Other,inConclusionStillNecessaryForAdoptionOfCtnAsRoutineClinicalBiomarker
Other,inConclusionStillNecessaryForAdoptionOfCtnAsRoutineClinicalBiomarkerInPatients
Other,inConclusionStillNecessaryForAdoptionOfCtnAsRoutineClinicalBiomarkerInPatientsWithBreastCancer
Other,inconsistentResults
Other,increase
Other,increasedRisk
Other,increasedRiskAmongContraceptionUsers
Other,increasedRiskAmongCurrentContraceptionUsers
Other,increasedRiskAmongCurrentHormonalContraceptionUsers
Other,increasedRiskAmongHormonalContraceptionUsers
Other,increasedRiskOfBreastCancer
Other,increasedRiskOfBreastCancerAmongContraceptionUsers
Other,increasedRiskOfBreastCancerAmongCurrentContraceptionUsers
Other,increasedRiskOfBreastCancerAmongCurrentHormonalContraceptionUsers
Other,increasedRiskOfBreastCancerAmongHormonalContraceptionUsers
Other,increasedRiskWithUse
Other,increasedRiskWithUseOfLevonorgestrelIntrauterineSystem-both
Other,increasedRiskWithUseOfLevonorgestrelIntrauterineSystem-bothOfFindings
Other,increasedRiskWithUseOfLevonorgestrelIntrauterineSystem-bothOfImportantFindings
Other,increasedRiskWithUseOfLevonorgestrelIntrauterineSystem-bothOfPotentiallyImportantFindings
Other,increasedRiskWithUseOfLevonorgestrelSystem-both
Other,increasedRiskWithUseOfLevonorgestrelSystem-bothOfFindings
Other,increasedRiskWithUseOfLevonorgestrelSystem-bothOfImportantFindings
Other,increasedRiskWithUseOfLevonorgestrelSystem-bothOfPotentiallyImportantFindings
Other,increaseInContrast
Other,increaseInContrastAfterInjection
Other,independent
Other,independentFactor
Other,independentPrognosticFactor
Other,index
Other,indicator
Other,Information
Other,infraredFluorescent
Other,infraredFluorescentDye
Other,infraredFluorescentImaging
Other,infraredFluorescentImagingInNegative
Other,infraredFluorescentImagingInNegativeInVitro
Other,infraredFluorescentImagingInTripleNegative
Other,infraredFluorescentImagingInTripleNegativeInVitro
Other,infraredImaging
Other,infraredImagingInNegative
Other,infraredImagingInNegativeInVitro
Other,infraredImagingInTripleNegative
Other,infraredImagingInTripleNegativeInVitro
Other,initialResults
Other,injury
Other,inLongTermHasFound
Other,intake
Other,inTermHasFound
Other,intravenousAdministration
Other,intravenousAdministrationOfOsteopontin-750Probe
Other,introducedCxcr4-targetedPetProbe68ga-pentixafor
Other,introducedPetProbe68ga-pentixafor
Other,inTumorImaging
Other,invasiveBreastCancer
Other,invasiveDisease
Other,inverseAssociation
Other,inverseAssociationAmongWomen
Other,inverseAssociationAmongWomenWithBreastCancer
Other,inverseAssociationBetweenPrediagnosisDietaryIntake
Other,inverseAssociationBetweenPrediagnosisDietaryIntakeAmongWomen
Other,inverseAssociationBetweenPrediagnosisDietaryIntakeAmongWomenWithBreastCancer
Other,inverseAssociationBetweenPrediagnosisDietaryIntakeOfB-carotene
Other,inverseAssociationBetweenPrediagnosisDietaryIntakeOfB-caroteneAmongWomen
Other,inverseAssociationBetweenPrediagnosisDietaryIntakeOfB-caroteneAmongWomenWithBreastCancer
Other,inverseAssociationBetweenPrediagnosisIntake
Other,inverseAssociationBetweenPrediagnosisIntakeAmongWomen
Other,inverseAssociationBetweenPrediagnosisIntakeAmongWomenWithBreastCancer
Other,inverseAssociationBetweenPrediagnosisIntakeOfB-carotene
Other,inverseAssociationBetweenPrediagnosisIntakeOfB-caroteneAmongWomen
Other,inverseAssociationBetweenPrediagnosisIntakeOfB-caroteneAmongWomenWithBreastCancer
Other,involved
Other,involvedInCancerDevelopment
Other,involvedInDnaDamageRegulation
Other,IORT
Other,isIn
Other,issues
Other,issuesOfContrastAgents
Other,issuesOfExistingContrastAgents
Other,it
Other,itsMinimalSilverIonReleaseProfiles
Other,itsUse
Other,itsWidespreadUse
Other,january312018
Other,LABC
Other,lapatinibCombined
Other,largeCohort
Other,largeCohortOfPatients
Other,largeCohortOfPatientsInOutpatientClinic
Other,largeCohortOfPatientsWithAdenomas
Other,largeCohortOfPatientsWithAdenomasInOutpatientClinic
Other,largeCohortOfPatientsWithPituitaryAdenomas
Other,largeCohortOfPatientsWithPituitaryAdenomasInOutpatientClinic
Other,largelyConsistent
Other,largerProspectiveStudies
Other,largerStudies
Other,latestTreatmentOptions
Other,lesion
Other,life
Other,limitations
Other,limitedEvidence
Other,limitedEvidenceForAssociation
Other,limitedEvidenceForAssociationAmongWomen
Other,limitedEvidenceForAssociationAmongWomenWithBreastCancer
Other,limitedEvidenceForAssociationBetweenPrediagnosisDietaryIntake
Other,limitedEvidenceForAssociationBetweenPrediagnosisDietaryIntakeAmongWomen
Other,limitedEvidenceForAssociationBetweenPrediagnosisDietaryIntakeAmongWomenWithBreastCancer
Other,limitedEvidenceForAssociationBetweenPrediagnosisDietaryIntakeOfB-carotene
Other,limitedEvidenceForAssociationBetweenPrediagnosisDietaryIntakeOfB-caroteneAmongWomen
Other,limitedEvidenceForAssociationBetweenPrediagnosisDietaryIntakeOfB-caroteneAmongWomenWithBreastCancer
Other,limitedEvidenceForAssociationBetweenPrediagnosisIntake
Other,limitedEvidenceForAssociationBetweenPrediagnosisIntakeAmongWomen
Other,limitedEvidenceForAssociationBetweenPrediagnosisIntakeAmongWomenWithBreastCancer
Other,limitedEvidenceForAssociationBetweenPrediagnosisIntakeOfB-carotene
Other,limitedEvidenceForAssociationBetweenPrediagnosisIntakeOfB-caroteneAmongWomen
Other,limitedEvidenceForAssociationBetweenPrediagnosisIntakeOfB-caroteneAmongWomenWithBreastCancer
Other,limitedEvidenceForInverseAssociation
Other,limitedEvidenceForInverseAssociationAmongWomen
Other,limitedEvidenceForInverseAssociationAmongWomenWithBreastCancer
Other,limitedEvidenceForInverseAssociationBetweenPrediagnosisDietaryIntake
Other,limitedEvidenceForInverseAssociationBetweenPrediagnosisDietaryIntakeAmongWomen
Other,limitedEvidenceForInverseAssociationBetweenPrediagnosisDietaryIntakeAmongWomenWithBreastCancer
Other,limitedEvidenceForInverseAssociationBetweenPrediagnosisDietaryIntakeOfB-carotene
Other,limitedEvidenceForInverseAssociationBetweenPrediagnosisDietaryIntakeOfB-caroteneAmongWomen
Other,limitedEvidenceForInverseAssociationBetweenPrediagnosisDietaryIntakeOfB-caroteneAmongWomenWithBreastCancer
Other,limitedEvidenceForInverseAssociationBetweenPrediagnosisIntake
Other,limitedEvidenceForInverseAssociationBetweenPrediagnosisIntakeAmongWomen
Other,limitedEvidenceForInverseAssociationBetweenPrediagnosisIntakeAmongWomenWithBreastCancer
Other,limitedEvidenceForInverseAssociationBetweenPrediagnosisIntakeOfB-carotene
Other,limitedEvidenceForInverseAssociationBetweenPrediagnosisIntakeOfB-caroteneAmongWomen
Other,limitedEvidenceForInverseAssociationBetweenPrediagnosisIntakeOfB-caroteneAmongWomenWithBreastCancer
Other,limitedEvidenceForSignificantlyInverseAssociation
Other,limitedEvidenceForSignificantlyInverseAssociationAmongWomen
Other,limitedEvidenceForSignificantlyInverseAssociationAmongWomenWithBreastCancer
Other,limitedEvidenceForSignificantlyInverseAssociationBetweenPrediagnosisDietaryIntake
Other,limitedEvidenceForSignificantlyInverseAssociationBetweenPrediagnosisDietaryIntakeAmongWomen
Other,limitedEvidenceForSignificantlyInverseAssociationBetweenPrediagnosisDietaryIntakeAmongWomenWithBreastCancer
Other,limitedEvidenceForSignificantlyInverseAssociationBetweenPrediagnosisDietaryIntakeOfB-carotene
Other,limitedEvidenceForSignificantlyInverseAssociationBetweenPrediagnosisDietaryIntakeOfB-caroteneAmongWomen
Other,limitedEvidenceForSignificantlyInverseAssociationBetweenPrediagnosisDietaryIntakeOfB-caroteneAmongWomenWithBreastCancer
Other,limitedEvidenceForSignificantlyInverseAssociationBetweenPrediagnosisIntake
Other,limitedEvidenceForSignificantlyInverseAssociationBetweenPrediagnosisIntakeAmongWomen
Other,limitedEvidenceForSignificantlyInverseAssociationBetweenPrediagnosisIntakeAmongWomenWithBreastCancer
Other,limitedEvidenceForSignificantlyInverseAssociationBetweenPrediagnosisIntakeOfB-carotene
Other,limitedEvidenceForSignificantlyInverseAssociationBetweenPrediagnosisIntakeOfB-caroteneAmongWomen
Other,limitedEvidenceForSignificantlyInverseAssociationBetweenPrediagnosisIntakeOfB-caroteneAmongWomenWithBreastCancer
Other,locoregionalRadiotherapy
Other,longScanTime
Other,longTime
Other,lowCtnLevels
Other,lowDiagnosticSensitivity
Other,lowDiagnosticSensitivityForWomen
Other,lowDiagnosticSensitivityForWomenWithBreasts
Other,lowDiagnosticSensitivityForWomenWithDenseBreasts
Other,low-doseAspirinUse
Other,lower
Other,lowSensitivity
Other,lowSensitivityForWomen
Other,lowSensitivityForWomenWithBreasts
Other,lowSensitivityForWomenWithDenseBreasts
Other,lungCancerInHuman
Other,mainAnalysis
Other,majorConcerns
Other,malign
Other,mammographicImages
Other,mammography
Other,management
Other,managementOfHer2
Other,managementOfRecurrentHer2
Other,managementOfSymptoms
Other,managementOfTumour-relatedSymptoms
Other,manyFeatures
Other,markedReduction
Other,massSpectrometry
Other,mayIndicative
Other,mayIndicativeOfBenignLesion
Other,mayIndicativeOfLesion
Other,maySmall
Other,mayTooSmall
Other,mayUsed
Other,mayUsedForTumourShrinkage
Other,mayUsedForTumourShrinkagePrior
Other,mayUsedForTumourShrinkagePriorToSurgery
Other,meanSuvmax
Other,meanSuvmaxOf35
Other,measured
Other,mechanisms
Other,mechanismsOfCarcinogenesis
Other,medianAge
Other,medianAmount
Other,medianFollow-up
Other,medianFollow-upOf48Years
Other,medicalConsultation
Other,membraneTypeMannoseReceptor
Other,membraneTypeMr
Other,meta-analysis
Other,Metastases
Other,metastaticDisease
Other,metastaticDiseaseOnPresentation
Other,micelles
Other,misdiagnosis
Other,missed
Other,model
Other,modified
Other,modifiedFactor
Other,molecularMechanisms
Other,molecularMechanismsOfCarcinogenesis
Other,moleculeInhibitors
Other,moreCommonlyDiagnosed
Other,moreDirectional
Other,moreRecentlyHaveDeveloped
Other,moreSpecificApplications
Other,most
Other,mostCommonAgents
Other,mostCommonAgentsUsed
Other,mostCommonAgentsUsedInBreastCancerTreatment
Other,mostCommonCancer
Other,mostEffectiveTechniqueused
Other,mostInvasiveDisease
Other,mostPatients
Other,mostPatientsInStudy
Other,mostSensitiveTest
Other,mostSensitiveTestForBreastCancerDetection
Other,MRI
Other,mriProtocols
Other,mriTechniques
Other,MSOT
Other,msotImaging
Other,multipleFactors
Other,multipleStudies
Other,multiresolutionResult
Other,mustAddressed
Other,mustAddressedDuringCancerCounselingConsultations
Other,mustAddressedDuringCancerGeneticCounselingConsultations
Other,mutationalStatus
Other,mutationalStatusBesidesFamilyHistory
Other,mutations
Other,myocardialInjury
Other,NAC
Other,nationwideRegistries
Other,necessary
Other,necessaryForAdoptionAsBiomarker
Other,necessaryForAdoptionAsBiomarkerInPatients
Other,necessaryForAdoptionAsBiomarkerInPatientsWithBreastCancer
Other,necessaryForAdoptionAsClinicalBiomarker
Other,necessaryForAdoptionAsClinicalBiomarkerInPatients
Other,necessaryForAdoptionAsClinicalBiomarkerInPatientsWithBreastCancer
Other,necessaryForAdoptionAsRoutineBiomarker
Other,necessaryForAdoptionAsRoutineBiomarkerInPatients
Other,necessaryForAdoptionAsRoutineBiomarkerInPatientsWithBreastCancer
Other,necessaryForAdoptionAsRoutineClinicalBiomarker
Other,necessaryForAdoptionAsRoutineClinicalBiomarkerInPatients
Other,necessaryForAdoptionAsRoutineClinicalBiomarkerInPatientsWithBreastCancer
Other,necessaryForAdoptionOfCtnAsBiomarker
Other,necessaryForAdoptionOfCtnAsBiomarkerInPatients
Other,necessaryForAdoptionOfCtnAsBiomarkerInPatientsWithBreastCancer
Other,necessaryForAdoptionOfCtnAsClinicalBiomarker
Other,necessaryForAdoptionOfCtnAsClinicalBiomarkerInPatients
Other,necessaryForAdoptionOfCtnAsClinicalBiomarkerInPatientsWithBreastCancer
Other,necessaryForAdoptionOfCtnAsRoutineBiomarker
Other,necessaryForAdoptionOfCtnAsRoutineBiomarkerInPatients
Other,necessaryForAdoptionOfCtnAsRoutineBiomarkerInPatientsWithBreastCancer
Other,necessaryForAdoptionOfCtnAsRoutineClinicalBiomarker
Other,necessaryForAdoptionOfCtnAsRoutineClinicalBiomarkerInPatients
Other,necessaryForAdoptionOfCtnAsRoutineClinicalBiomarkerInPatientsWithBreastCancer
Other,necessity
Other,needed
Other,negativeFamilyHistory
Other,neoadjuvantAnti-her2Treatment
Other,neoadjuvantTreatment
Other,networkClassifier
Other,neuralNetworkClassifier
Other,neuroma
Other,neuropathicBreastPain
Other,newlyIdentified
Other,newValue-basedHealthcareParadigm
Other,non-functioningPituitaryAdenomas
Other,non-ideal
Other,notablyDesigned
Other,novelClinicalStrategies
Other,novelOptions
Other,novelPowerfulTechnique
Other,novelStrategies
Other,novelTargetedOptions
Other,novelTargetedTherapeuticOptions
Other,novelTechnique
Other,novelTherapeuticOptions
Other,numerousGene-expression-basedPrognosticSignatures
Other,numerousGene-expression-basedSignatures
Other,numerousPrognosticSignatures
Other,numerousSignatures
Other,observationalStudies
Other,observedVariation
Other,obtained
Other,onePatient
Other,oneYear
Other,one-yearExposureLag
Other,oneYearOfDiseaseControl
Other,oneYearOfDiseaseControlWithoutDeterioration
Other,oneYearOfDiseaseControlWithoutDeteriorationInHerEjectionFraction
Other,oneYearWithoutDeterioration
Other,oneYearWithoutDeteriorationInHerEjectionFraction
Other,only35Cases
Other,only35CasesOfBreastNeuromas
Other,only35CasesOfTraumaticBreastNeuromas
Other,onlyCases
Other,onlyFewCases
Other,onlyFewCasesHavingReportedToDate
Other,onlyRoutinelyImplemented
Other,onlyRoutinelyImplementedInScreeningAtIncreasedRisk
Other,onlyRoutinelyImplementedInScreeningAtIncreasedRiskOfBreastCancer
Other,onlyRoutinelyImplementedInScreeningAtRisk
Other,onlyRoutinelyImplementedInScreeningAtRiskOfBreastCancer
Other,onlyRoutinelyImplementedInScreeningOfWomenAtIncreasedRisk
Other,onlyRoutinelyImplementedInScreeningOfWomenAtIncreasedRiskOfBreastCancer
Other,onlyRoutinelyImplementedInScreeningOfWomenAtRisk
Other,onlyRoutinelyImplementedInScreeningOfWomenAtRiskOfBreastCancer
Other,options
Other,osteopontin-750Accumulation
Other,osteopontin-basedProbe
Other,osteopontinPeptide
Other,otherGenes
Other,ourBiologyExperimentData
Other,ourExperience
Other,ourExperienceOfHigh-doseRadiotherapy
Other,ourExperienceOfRadiotherapy
Other,ourFindings
Other,ourLiteratureReview
Other,ourMolecularBiologyExperimentData
Other,ourPreliminaryBiologyExperimentData
Other,ourPreliminaryMolecularBiologyExperimentData
Other,outcome
Other,outcomeOverCosts
Other,outcomes
Other,outcomesOfEstrogenPositive
Other,outcomesOfEstrogenReceptorPositive
Other,outcomesOfPositive
Other,outcomesOfReceptorPositive
Other,outcomeWithGoodNegativePredictiveValue
Other,outcomeWithGoodNegativeValue
Other,outcomeWithGoodPredictiveValue
Other,outcomeWithGoodValue
Other,outcomeWithNegativePredictiveValue
Other,outcomeWithNegativeValue
Other,outcomeWithPredictiveValue
Other,outcomeWithValue
Other,outpatientClinic
Other,overview
Other,overviewOfAbbreviatedBreastMriProtocols
Other,overviewOfBreastMriProtocols
Other,p
Other,parpInhibitors-basedTreatments
Other,parpTreatments
Other,particular
Other,patientDemographics
Other,patientsInStudy
Other,patient'sOutcome
Other,patient'sOutcomeOverCosts
Other,patientsWithBreastCancer
Other,patientsWithBreastCancerReceiving
Other,patientsWithBreastCancerReceivingWithAnthracyclines
Other,patientsWithHistoryOfBreastSurgery
Other,patientsWithHistoryOfTranstuzumab-inducedCardiacDysfunction
Other,patientsWithLabc
Other,patientsWithPrimaryBreastCancer
Other,patientsWithProlactinoma
Other,patientWithHer2
Other,patientWithRelapsedHer2
Other,pegylatedMicelles
Other,percecnt
Other,percecntConfidenceIntervals
Other,performance
Other,performanceInPatients
Other,performanceInPatientsWithBreastCancer
Other,performanceOfCxcr4-directedPetImaging
Other,performanceOfCxcr4-directedPetImagingInPatients
Other,performanceOfCxcr4-directedPetImagingInPatientsWithBreastCancer
Other,performanceOfPetImaging
Other,performanceOfPetImagingInPatients
Other,performanceOfPetImagingInPatientsWithBreastCancer
Other,performed
Other,performedFromInceptionToJanuary312018
Other,petImaging
Other,petProbe68ga-pentixafor
Other,phantomImaging
Other,pharmacologicalInduction
Other,physicalFinding
Other,platinumSalts
Other,population
Other,populationOfTnbcPatients
Other,positiveFamilyHistoryOfMalignancy
Other,post-diagnosisAspirinUse
Other,post-diagnosisLow-doseAspirinUse
Other,postmenopausalPatient
Other,potential
Other,potentialAsContrastAgent
Other,potentialAsContrastAgentForBreastCancerDiagnosis
Other,potentialAsEffectiveContrastAgent
Other,potentialAsEffectiveContrastAgentForBreastCancerDiagnosis
Other,potentialAsEffectiveMultimodalContrastAgent
Other,potentialAsEffectiveMultimodalContrastAgentForBreastCancerDiagnosis
Other,potentialAsMultimodalContrastAgent
Other,potentialAsMultimodalContrastAgentForBreastCancerDiagnosis
Other,potentialOfAion
Other,potentialOfAionAsContrastAgent
Other,potentialOfAionAsContrastAgentForBreastCancerDiagnosis
Other,potentialOfAionAsEffectiveContrastAgent
Other,potentialOfAionAsEffectiveContrastAgentForBreastCancerDiagnosis
Other,potentialOfAionAsEffectiveMultimodalContrastAgent
Other,potentialOfAionAsEffectiveMultimodalContrastAgentForBreastCancerDiagnosis
Other,potentialOfAionAsMultimodalContrastAgent
Other,potentialOfAionAsMultimodalContrastAgentForBreastCancerDiagnosis
Other,powerfulTechnique
Other,preciseTool
Other,preciseToolForTargetedTreatment
Other,preciseToolForTargetedTreatmentIncludingBc
Other,preciseToolForTargetedTreatmentOfCancer
Other,preciseToolForTargetedTreatmentOfCancerIncludingBc
Other,preciseToolForTreatment
Other,preciseToolForTreatmentIncludingBc
Other,preciseToolForTreatmentOfCancer
Other,preciseToolForTreatmentOfCancerIncludingBc
Other,preclinicalPhase
Other,presence
Other,presenceAtPresentation
Other,presenceOfDisease
Other,presenceOfDiseaseAtPresentation
Other,presenceOfMetastaticDisease
Other,presenceOfMetastaticDiseaseAtPresentation
Other,present
Other,presenting
Other,presentingWithBreastPain
Other,presentingWithNeuropathicBreastPain
Other,presentingWithRefractoryBreastPain
Other,presentingWithRefractoryNeuropathicBreastPain
Other,previousBreast/axillarySurgery
Other,previousDecades
Other,previousStudies
Other,primaryBreastCancer
Other,primaryBreastCancerPatientsTreatedBetween01012010
Other,primaryTumour
Other,probe
Other,processing
Other,prognostic
Other,prognosticFactor
Other,prognosticSignatures
Other,prognosticValue
Other,prolongedRecovery
Other,properlySelectedCases
Other,properlySelectedCasesWithAsymptomaticNeuromas
Other,properlySelectedCasesWithNeuromas
Other,prospectiveStudies
Other,protected
Other,radicalSurgicalApproaches
Other,radiotherapy
Other,randomEffectsModel
Other,rare
Other,rareCase
Other,rareCaseOfBreastNeuroma
Other,rareCaseOfTraumaticBreastNeuroma
Other,rareClinicalEntity
Other,rareClinicalEntityWithCases
Other,rareClinicalEntityWithCasesHavingReported
Other,rareClinicalEntityWithCasesHavingReportedToDate
Other,rareClinicalEntityWithFewCases
Other,rareClinicalEntityWithFewCasesHavingReported
Other,rareClinicalEntityWithFewCasesHavingReportedToDate
Other,rareClinicalEntityWithOnlyCases
Other,rareClinicalEntityWithOnlyCasesHavingReported
Other,rareClinicalEntityWithOnlyCasesHavingReportedToDate
Other,rareClinicalEntityWithOnlyFewCases
Other,rareClinicalEntityWithOnlyFewCasesHavingReported
Other,rareClinicalEntityWithOnlyFewCasesHavingReportedToDate
Other,rareEntity
Other,rareEntityWithCases
Other,rareEntityWithCasesHavingReported
Other,rareEntityWithCasesHavingReportedToDate
Other,rareEntityWithFewCases
Other,rareEntityWithFewCasesHavingReported
Other,rareEntityWithFewCasesHavingReportedToDate
Other,rareEntityWithOnlyCases
Other,rareEntityWithOnlyCasesHavingReported
Other,rareEntityWithOnlyCasesHavingReportedToDate
Other,rareEntityWithOnlyFewCases
Other,rareEntityWithOnlyFewCasesHavingReported
Other,rareEntityWithOnlyFewCasesHavingReportedToDate
Other,recentCohortStudy
Other,recentDanishCohortStudy
Other,recentlyFound
Other,recentlyHaveDeveloped
Other,recentlyIntroducedCxcr4-targetedPetProbe68ga-pentixafor
Other,recentlyIntroducedPetProbe68ga-pentixafor
Other,recognized
Other,recombinationPathway
Other,recorded
Other,recurrentBreastCancer
Other,recurrentDisease
Other,reduction
Other,reductionInBrca1Levels
Other,refractoryBreastPain
Other,refractoryNeuropathicBreastPain
Other,region
Other,registries
Other,relapsedHer2
Other,related
Other,relationship
Other,relativesOfPatientsWithPa
Other,repair
Other,reported
Other,reportedInHigherProportion
Other,reportedInHigherProportionOfPatients
Other,reportedInHigherProportionOfPatientsWithPa
Other,reportedInProportion
Other,reportedInProportionOfPatients
Other,reportedInProportionOfPatientsWithPa
Other,reportedInSignificantlyHigherProportion
Other,reportedInSignificantlyHigherProportionOfPatients
Other,reportedInSignificantlyHigherProportionOfPatientsWithPa
Other,representativeGene-expression-basedSignatures
Other,representativeSignatures
Other,reproducibilityStudies
Other,required
Other,research
Other,reserved
Other,respondents
Other,response
Other,responsible
Other,result
Other,results
Other,retrospectiveAnalysis
Other,risk
Other,riskAmongContraceptionUsers
Other,riskAmongCurrentContraceptionUsers
Other,riskAmongCurrentHormonalContraceptionUsers
Other,riskAmongHormonalContraceptionUsers
Other,riskForMalignancy
Other,riskOfBreastCancer
Other,riskOfBreastCancerAmongContraceptionUsers
Other,riskOfBreastCancerAmongCurrentContraceptionUsers
Other,riskOfBreastCancerAmongCurrentHormonalContraceptionUsers
Other,riskOfBreastCancerAmongHormonalContraceptionUsers
Other,riskStratification
Other,riskWithUse
Other,riskWithUseOfLevonorgestrelIntrauterineSystem-both
Other,riskWithUseOfLevonorgestrelIntrauterineSystem-bothOfFindings
Other,riskWithUseOfLevonorgestrelIntrauterineSystem-bothOfImportantFindings
Other,riskWithUseOfLevonorgestrelIntrauterineSystem-bothOfPotentiallyImportantFindings
Other,riskWithUseOfLevonorgestrelSystem-both
Other,riskWithUseOfLevonorgestrelSystem-bothOfFindings
Other,riskWithUseOfLevonorgestrelSystem-bothOfImportantFindings
Other,riskWithUseOfLevonorgestrelSystem-bothOfPotentiallyImportantFindings
Other,role
Other,routineBiomarker
Other,routineBiomarkerInPatients
Other,routineBiomarkerInPatientsWithBreastCancer
Other,routineClinicalBiomarker
Other,routineClinicalBiomarkerInPatients
Other,routineClinicalBiomarkerInPatientsWithBreastCancer
Other,routinelyImplemented
Other,routinelyImplementedInScreeningAtIncreasedRisk
Other,routinelyImplementedInScreeningAtIncreasedRiskOfBreastCancer
Other,routinelyImplementedInScreeningAtRisk
Other,routinelyImplementedInScreeningAtRiskOfBreastCancer
Other,routinelyImplementedInScreeningOfWomenAtIncreasedRisk
Other,routinelyImplementedInScreeningOfWomenAtIncreasedRiskOfBreastCancer
Other,routinelyImplementedInScreeningOfWomenAtRisk
Other,routinelyImplementedInScreeningOfWomenAtRiskOfBreastCancer
Other,safetyIssues
Other,scanTime
Other,screening
Other,screeningBehavior
Other,screeningMammography
Other,screeningOfWomen
Other,screeningTools
Other,search
Other,second
Other,secondaryConfirmation
Other,secondaryConfirmationOfSignalAccumulation
Other,secondaryConfirmationOfSignalAccumulationUsing
Other,secondaryConfirmationOfSignalAccumulationUsingNearFluorescentImaging
Other,secondaryConfirmationOfSignalAccumulationUsingNearImaging
Other,secondaryConfirmationOfSignalAccumulationUsingNearInfraredFluorescentImaging
Other,secondaryConfirmationOfSignalAccumulationUsingNearInfraredImaging
Other,secondaryConfirmationUsing
Other,secondaryConfirmationUsingNearFluorescentImaging
Other,secondaryConfirmationUsingNearImaging
Other,secondaryConfirmationUsingNearInfraredFluorescentImaging
Other,secondaryConfirmationUsingNearInfraredImaging
Other,segmentationAlgorithm
Other,selectedCases
Other,selectedCasesWithAsymptomaticNeuromas
Other,selectedCasesWithNeuromas
Other,selectiveAccumulation
Other,selectiveAccumulationAnd
Other,selectiveAccumulationAndInVivo
Other,selectiveAccumulationInVitroAnd
Other,selectiveAccumulationInVitroAndInVivo
Other,selectiveAccumulationOfFluorescentOsteopontin
Other,selectiveAccumulationOfFluorescentOsteopontinAnd
Other,selectiveAccumulationOfFluorescentOsteopontinAndInVivo
Other,selectiveAccumulationOfFluorescentOsteopontinInVitroAnd
Other,selectiveAccumulationOfFluorescentOsteopontinInVitroAndInVivo
Other,selectiveAccumulationOfOsteopontin
Other,selectiveAccumulationOfOsteopontinAnd
Other,selectiveAccumulationOfOsteopontinAndInVivo
Other,selectiveAccumulationOfOsteopontinInVitroAnd
Other,selectiveAccumulationOfOsteopontinInVitroAndInVivo
Other,selectiveBinding
Other,sensitive
Other,sensitiveTest
Other,sensitiveTestForBreastCancerDetection
Other,sensitivity
Other,sensitivityForWomen
Other,sensitivityForWomenWithBreasts
Other,sensitivityForWomenWithDenseBreasts
Other,seromaFormation
Other,severalGene-expression-basedSignatures
Other,severalRepresentativeGene-expression-basedSignatures
Other,severalRepresentativeSignatures
Other,severalSignatures
Other,shaped
Other,She
Other,signalIntensity
Other,signature
Other,signatures
Other,significantAdvances
Other,significantlyHigher
Other,significantlyHigherThanInFamilies
Other,significantlyHigherThanInFamiliesOfNfpaPatients
Other,significantlyInverseAssociation
Other,significantlyInverseAssociationAmongWomen
Other,significantlyInverseAssociationAmongWomenWithBreastCancer
Other,significantlyInverseAssociationBetweenPrediagnosisDietaryIntake
Other,significantlyInverseAssociationBetweenPrediagnosisDietaryIntakeAmongWomen
Other,significantlyInverseAssociationBetweenPrediagnosisDietaryIntakeAmongWomenWithBreastCancer
Other,significantlyInverseAssociationBetweenPrediagnosisDietaryIntakeOfB-carotene
Other,significantlyInverseAssociationBetweenPrediagnosisDietaryIntakeOfB-caroteneAmongWomen
Other,significantlyInverseAssociationBetweenPrediagnosisDietaryIntakeOfB-caroteneAmongWomenWithBreastCancer
Other,significantlyInverseAssociationBetweenPrediagnosisIntake
Other,significantlyInverseAssociationBetweenPrediagnosisIntakeAmongWomen
Other,significantlyInverseAssociationBetweenPrediagnosisIntakeAmongWomenWithBreastCancer
Other,significantlyInverseAssociationBetweenPrediagnosisIntakeOfB-carotene
Other,significantlyInverseAssociationBetweenPrediagnosisIntakeOfB-caroteneAmongWomen
Other,significantlyInverseAssociationBetweenPrediagnosisIntakeOfB-caroteneAmongWomenWithBreastCancer
Other,significantlyLower
Other,significantPrognosticValue
Other,significantValue
Other,similar
Other,similarTowaveletFilter
Other,sixGlycosylationSites
Other,smallMoleculeInhibitors
Other,smallPatientCohort
Other,soFarHasAssociated
Other,soFarHasAssociatedWithMutations
Other,soFarHasAssociatedWithMutationsInBrca1
Other,soFarHasMainlyAssociated
Other,soFarHasMainlyAssociatedWithMutations
Other,soFarHasMainlyAssociatedWithMutationsInBrca1
Other,specificCancerCell-relatedComponents
Other,specificCancerComponents
Other,stageIiiBreastCaner
Other,standardizedImagingProtocol
Other,status
Other,statusBesidesFamilyHistory
Other,stillNecessary
Other,stillNecessaryForAdoptionAsBiomarker
Other,stillNecessaryForAdoptionAsBiomarkerInPatients
Other,stillNecessaryForAdoptionAsBiomarkerInPatientsWithBreastCancer
Other,stillNecessaryForAdoptionAsClinicalBiomarker
Other,stillNecessaryForAdoptionAsClinicalBiomarkerInPatients
Other,stillNecessaryForAdoptionAsClinicalBiomarkerInPatientsWithBreastCancer
Other,stillNecessaryForAdoptionAsRoutineBiomarker
Other,stillNecessaryForAdoptionAsRoutineBiomarkerInPatients
Other,stillNecessaryForAdoptionAsRoutineBiomarkerInPatientsWithBreastCancer
Other,stillNecessaryForAdoptionAsRoutineClinicalBiomarker
Other,stillNecessaryForAdoptionAsRoutineClinicalBiomarkerInPatients
Other,stillNecessaryForAdoptionAsRoutineClinicalBiomarkerInPatientsWithBreastCancer
Other,stillNecessaryForAdoptionOfCtnAsBiomarker
Other,stillNecessaryForAdoptionOfCtnAsBiomarkerInPatients
Other,stillNecessaryForAdoptionOfCtnAsBiomarkerInPatientsWithBreastCancer
Other,stillNecessaryForAdoptionOfCtnAsClinicalBiomarker
Other,stillNecessaryForAdoptionOfCtnAsClinicalBiomarkerInPatients
Other,stillNecessaryForAdoptionOfCtnAsClinicalBiomarkerInPatientsWithBreastCancer
Other,stillNecessaryForAdoptionOfCtnAsRoutineBiomarker
Other,stillNecessaryForAdoptionOfCtnAsRoutineBiomarkerInPatients
Other,stillNecessaryForAdoptionOfCtnAsRoutineBiomarkerInPatientsWithBreastCancer
Other,stillNecessaryForAdoptionOfCtnAsRoutineClinicalBiomarker
Other,stillNecessaryForAdoptionOfCtnAsRoutineClinicalBiomarkerInPatients
Other,stillNecessaryForAdoptionOfCtnAsRoutineClinicalBiomarkerInPatientsWithBreastCancer
Other,strategies
Other,stratified
Other,strong
Other,strongAssociation
Other,strongContrast
Other,strongContrastWithImagingModalities
Other,strongFactor
Other,strongFamilyHistory
Other,strongFamilyHistoryOfCancer
Other,strongIndependentFactor
Other,strongIndependentPrognosticFactor
Other,strongPrognosticFactor
Other,studies
Other,study
Other,subcutaneousBreastTumor
Other,subcutaneousBreastTumorInMice
Other,subcutaneousBreastTumorInNudeMice
Other,subjectiveRisk
Other,subtype-specificPrognosticSignatures
Other,subtype-specificSignature
Other,subtype-specificSignatures
Other,summaryHazardRatioOf070ForHighestIntake
Other,summaryHazardRatios
Other,surgicalExcision
Other,surveillance
Other,SUVmax
Other,suvmaxOf35
Other,symptomControl
Other,systemicTherapy
Other,targetedImmuneCell
Other,targetedOptions
Other,targetedTherapeuticOptions
Other,technique
Other,techniqueused
Other,tenStudies
Other,test
Other,testForBreastCancerDetection
Other,thanFamilies
Other,thanFamiliesOfPatients
Other,thanFamiliesOfPatientsWithAdenomas
Other,thanFamiliesOfPatientsWithNon-functioningAdenomas
Other,thanFamiliesOfPatientsWithNon-functioningPituitaryAdenomas
Other,thanFamiliesOfPatientsWithPituitaryAdenomas
Other,thanKidney
Other,the
Other,theirAbility
Other,theirAbilityInTheirOriginallyTargetedPopulations
Other,theirAbilityInTheirOriginallyTargetedPopulationsOfBreastCancer
Other,theirAbilityInTheirPopulations
Other,theirAbilityInTheirPopulationsOfBreastCancer
Other,theirAbilityInTheirTargetedPopulations
Other,theirAbilityInTheirTargetedPopulationsOfBreastCancer
Other,theirAbilityOfPrognosisPrediction
Other,theirAbilityOfPrognosisPredictionInTheirOriginallyTargetedPopulations
Other,theirAbilityOfPrognosisPredictionInTheirOriginallyTargetedPopulationsOfBreastCancer
Other,theirAbilityOfPrognosisPredictionInTheirPopulations
Other,theirAbilityOfPrognosisPredictionInTheirPopulationsOfBreastCancer
Other,theirAbilityOfPrognosisPredictionInTheirTargetedPopulations
Other,theirAbilityOfPrognosisPredictionInTheirTargetedPopulationsOfBreastCancer
Other,theirBeliefs
Other,theirBeliefsRegardingCancerCausation
Other,theirCardiotoxicities
Other,theirEmergingRole
Other,theirExperiences
Other,theirExperiencesLiving
Other,theirExperiencesLivingWithSister
Other,theirInhibition
Other,theirOriginallyTargetedPopulationsOfBreastCancer
Other,them
Other,thematicAnalysis
Other,themselves
Other,therapeuticApproachesEspeciallyUnderViewOfCurrentDevelopments
Other,therapeuticBenefits
Other,therapeuticOptions
Other,therapy
Other,thereforeHasApplied
Other,thereforeHasAppliedToEarlyIdentification
Other,thereforeHasAppliedToIdentification
Other,theResulting
Other,thesuspiciousRegion
Other,They
Other,third-degree
Other,thirteenPatients
Other,thusWouldCrucial
Other,thusWouldCrucialForApplication
Other,thusWouldCrucialForApplicationOfPreventiveStrategies
Other,thusWouldCrucialForApplicationOfStrategies
Other,time
Other,time-varyingAspirinUse
Other,time-varyingLow-doseAspirinUse
Other,time-varyingPost-diagnosisAspirinUse
Other,time-varyingPost-diagnosisLow-doseAspirinUse
Other,tissueSampling
Other,tnbcCells
Other,tool
Other,toolForTargetedTreatment
Other,toolForTargetedTreatmentIncludingBc
Other,toolForTargetedTreatmentOfCancer
Other,toolForTargetedTreatmentOfCancerIncludingBc
Other,toolForTreatment
Other,toolForTreatmentIncludingBc
Other,toolForTreatmentOfCancer
Other,toolForTreatmentOfCancerIncludingBc
Other,total
Other,towaveletFilter
Other,Transcripts
Other,transferable
Other,traumaticBreastNeuromas
Other,traumaticNeuroma
Other,treatment
Other,treatmentOptions
Other,trendForLessRadicalSurgicalApproachesInBreastCancerDueBetterUnderstandingOfTumourBiology
Other,tripleNegativeInVitro
Other,troponins
Other,tumorBed
Other,tumorDetectability
Other,tumorImaging
Other,tumor-to-backgroundRatios
Other,type
Other,typeOfPa
Other,typeOfSurgery
Other,Ulceration
Other,understand
Other,understanding
Other,underutilized
Other,unenhancedMriTechniques
Other,unresectable
Other,unresectedLocallyAdvancedBreastCancer
Other,unusual
Other,update
Other,updateOnRiskFactors
Other,updateOnRiskFactorsForSeromaProduction
Other,updateOnRiskFactorsForSeromaProductionAfterBreastCancerSurgery
Other,urgentlyNeeded
Other,use
Other,used
Other,useOfAdvancedImagingExaminations
Other,useOfImagingExaminations
Other,useOfLevonorgestrelIntrauterineSystem-bothOfPotentiallyImportantFindings
Other,value
Other,variableMechanisms
Other,variableMechanismsOfCarcinogenesis
Other,variableMolecularMechanisms
Other,variableMolecularMechanismsOfCarcinogenesis
Other,veryComplexDisease
Other,veryRareCase
Other,veryRareCaseOfBreastNeuroma
Other,veryRareCaseOfTraumaticBreastNeuroma
Other,veryRareClinicalEntity
Other,veryRareClinicalEntityWithCases
Other,veryRareClinicalEntityWithCasesHavingReported
Other,veryRareClinicalEntityWithCasesHavingReportedToDate
Other,veryRareClinicalEntityWithFewCases
Other,veryRareClinicalEntityWithFewCasesHavingReported
Other,veryRareClinicalEntityWithFewCasesHavingReportedToDate
Other,veryRareClinicalEntityWithOnlyCases
Other,veryRareClinicalEntityWithOnlyCasesHavingReported
Other,veryRareClinicalEntityWithOnlyCasesHavingReportedToDate
Other,veryRareClinicalEntityWithOnlyFewCases
Other,veryRareClinicalEntityWithOnlyFewCasesHavingReported
Other,veryRareClinicalEntityWithOnlyFewCasesHavingReportedToDate
Other,veryRareEntity
Other,veryRareEntityWithCases
Other,veryRareEntityWithCasesHavingReported
Other,veryRareEntityWithCasesHavingReportedToDate
Other,veryRareEntityWithFewCases
Other,veryRareEntityWithFewCasesHavingReported
Other,veryRareEntityWithFewCasesHavingReportedToDate
Other,veryRareEntityWithOnlyCases
Other,veryRareEntityWithOnlyCasesHavingReported
Other,veryRareEntityWithOnlyCasesHavingReportedToDate
Other,veryRareEntityWithOnlyFewCases
Other,veryRareEntityWithOnlyFewCasesHavingReported
Other,veryRareEntityWithOnlyFewCasesHavingReportedToDate
Other,visuallyDetectable
Other,we
Other,whenPresent
Other,widerPopulation
Other,widerPopulationOfTnbcPatients
Other,wouldCrucial
Other,wouldCrucialForApplication
Other,wouldCrucialForApplicationOfPreventiveStrategies
Other,wouldCrucialForApplicationOfStrategies
Other,woundDrains
Other,woundDrainsPlaced
Other,woundDrainsPlacedInBreast
Other,x-rayMammography
Other,years2005-2017
Other,youngPatients
Species,human
Species,nudeMice
Species,patient
Species,patients
Species,People
Species,women